








Title of Document: Simultaneous transcriptome profiling of 
Trypanosoma cruzi parasites and their 
human host cells.   
  
 Yuan Li, Doctor of Philosophy, 2014 
  
Directed By: Dr. Najib M. El-Sayed, Associate Professor 





The genome of the kinetoplastid parasite Trypanosoma cruzi, causative agent of 
Chagas disease, was published nine years ago, yet a systematic and 
comprehensive analysis of the transcriptomes of the parasite and the human 
host has not been conducted. The parasite responds rapidly to transmission 
between arthropod vectors and mammalian hosts by undergoing complex cellular 
differentiation processes that are not well understood. In this study, we generated 
the first transcriptome map for both T. cruzi and infected human host cells across 
the infection cycle including time points of 4, 6, 12, 24, 48 and 72 hours post 
invasion with the next generation RNA sequencing technology (RNA-Seq). We 
also captured the transcriptome of the parasite in its bloodstream form 
(trypomastigote) and its replicative form inside insect vector (epimastigote). We 
successfully mapped transcribed regions for the pathogen at single nucleotide 
 
 
resolution on a genomic scale and characterized the RNA processing (trans-
splicing and polyadenylation) events across its various developmental stages. 
Here we report the prevalent heterogeneity of RNA processing sites across the 
genome. We also note the preference of different primary sites in various 
developmental stages presenting as a potential and interesting approach of 
posttranscriptional regulation, which may hypothetically contribute to the survival 
of the parasite across different environments. Our work has significantly 
enhanced the current genome annotation of T. cruzi. In addition, using the T. 
cruzi and human genome sequence as reference, we explored these data with 
informatics tools to identify genes with significant regulation and successfully 
profiled gene expressions from both species simultaneously. We examined the 
subsets of differentially expressed genes both in the parasite and the host cell 
over the course of the infection to understand the mechanisms of invasion and 
intracellular survival strategy as well as host-pathogen interactions. T. cruzi 
genes that were significantly regulated during the infection process might present 
as new targets for drug development, whereas human genes that were 
significantly regulated might signal the immunoinflammatory response triggered 
by the manipulation of the parasite. Furthermore, we investigated the gene 
expression patterns of T. cruzi across its different developmental stages, 
clustered gene with similar patterns, and identified possible sequence motifs in 
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 Chapter 1 Introduction 
1.1 Chagas disease 
1.1.1 Trypanosoma cruzi  
Trypanosoma cruzi is an intracellular protozoan parasite and the etiological agent 
of Chagas disease, or American trypanosomiasis. It was first discovered in 1909 
by Brazilian physician Dr. Carlos Chagas. He named the pathogen after his 
mentor Oswaldo Cruz. Chagas’ original report described in great detail both the 
cycle of transmission and the acute clinical manifestation of the first human case. 
Findings from paleoparasitology studies have recovered T. cruzi DNA from 
human mummies and showed that the presence of Chagas disease can be dated 
as early as 9000 years ago (Aufderheide, Salo et al. 2004).  Notably, it has been 
hypothesized that Charles Darwin might have suffered from Chagas disease as 
the result of the bite of triatomine during his expedition to South America in 1835, 
suggested by his vivid description of contact with the kissing bug and by some of 
his symptoms in later life (Bernstein 1984).  
1.1.2 The life cycle of T. cruzi 
The T. cruzi life cycle is complex and consists of several distinct life stages, 
morphological states and hosts with three main developmental forms: 
epimastigote, trypomastigote and amastigote (Rassi, Rassi et al. 2010) (Figure 
1). Epimastigotes proliferate in the midgut of Triatomine insects that feed on 





Figure 1  Life cycle of T. cruzi 
Cell invasion by infective trypomastigotes after host scratch near the bite site on 
the skin is followed by transformation into replicative amastigotes and multiple 
binary divisions in the cell cytoplasm. Upon the rupture of the host cell, released 
trypomastigotes can either start another infection cycle or get picked up by the 




trypomastigotes that are released by defecation. These trypomastigotes enter 
mammalian cells and transform into proliferative amastigote forms. When the 
local cells are swollen with amastigotes, they transform again into non-dividing 
and infective trypomastigotes. Trypomastigotes lyse infected cells, invade 
adjacent tissues, and disseminate via the lymphatics and bloodstream to distant 
sites, mainly muscle cells and ganglion cells, where they undergo further cycles 
of intracellular multiplication (Brener 1971). To achieve successful completion of 
the life cycle, the parasite must rapidly adapt to different environments by 





1.1.3 Chagas disease 
1.1.3.1 Epidemiology 
Chagas disease is ranked as one of the most important pathogens throughout 
Central America and South America. According to countrywide survey done in 
the 1980s, more than 100 million people were exposed to the risk of infection and 
17.4 million were infected in 18 countries resulted in more than 50000 death per 
year (WHO 2002; Rassi, Rassi et al. 2010; Hotez, Dumonteil et al. 2013). The 
disease was correlated with poor living conditions and usually occurred in rural 
areas, in which vector borne transmission to man occurred.  In the past 20 years, 
great efforts, including improved vector control programs and compulsory blood-
bank screening, have been made to control new cases of infection and reduce 
disease prevalence (Moncayo 2003). Current estimates indicate that the number 
of infection cases decreased to 7.7 million, with the number of death per year 
dropped to 12500 per year (Moncayo 2003). However, the recent influx of 
immigrants from countries endemic for disease has suggested that Chagas 
disease is becoming an important health issue in the USA and Canada and in 
many parts of Europe and the western Pacific, where an increasing number of 
infected cases has been reported (Schmunis 1991; Martinez-Perez, Norman et 
al. 2014) (Figure 2). In USA, an estimated 300,167 individuals are infected with 







Figure 2 Estimated number of infections with T. cruzi outside endemic 
countries. 
Infected population in non-endemic countries is indicated in different colors and 
other infected populations in endemic regions are colored in grey. The recent 
influx of immigrants from countries endemic for disease has implied that Chagas 
disease is becoming an important health issue in the USA and Canada and in 
many parts of Europe and the western Pacific, where an increasing number of 







In the acute phase of Chagas disease, organ and tissue damage is caused by 
the invasion of the parasite and the immunoinflammatory response triggered by 
thepresence of the parasite (Tarleton and Zhang 1999; Soares, Pontes-De-
Carvalho et al. 2001; Marin-Neto, Cunha-Neto et al. 2007; Munoz-Saravia, 
Haberland et al. 2012). Several studies with experimental models of T. cruzi 
infection have reported that a strong T-helper-1 immune response with both CD4 
and CD8 cells and production of some specific cytokines, including interferon γ, 
tumor necrosis factor α, and interleukin 12 , plays key roles in the control of 
parasitism (Abrahamsohn and Coffman 1996; Aliberti, Cardoso et al. 1996; Silva, 
Aliberti et al. 1998; Martins, Vieira et al. 1999). The pathogenesis of chronic 
Chagas disease is controversial. Two main hypotheses have been developed to 
explain the main cause of tissue damage: one focuses on the direct parasite 
factors, and the other is based on the immunopathology or even the autoimmune 
mechanisms (Soares, Pontes-De-Carvalho et al. 2001; Marin-Neto, Cunha-Neto 
et al. 2007). However, a growing consensus indicates that the presence of 
pathogen is required for the development of the disease (Tarleton and Zhang 
1999; Tarleton 2003). The emergence of more sensitive diagnostic tests, such as 
polymerase chain reactions (PCRs), confirmed the persistence of the parasite 
deep inside myocardium (Britto, Cardoso et al. 1999; Brasil, De Castro et al. 
2010).  The balance between immune-mediated parasite containment and 
inflammation of the host tissue is important in the progression of the disease: if 




parasite burden and immune-mediated inflammation increased. On the contrary, 
a well-executed immune response, in which parasite load is lowered and 
inflammatory consequences are kept to a minimum, results in a better outcome 
(Tarleton 2003).  
 
The severe heart symptoms shown at late stage of Chagas disease is a result of 
slowly progressive and incessant myocarditis, which leads to the impairment of 
contractile function and dilatation of all four chambers. Histological examination 
shows widespread damage of myocardial cells, diffuse fibrosis, oedema, 
mononuclear cell infiltration in the myocardium and scarring of the conduction 
system (Andrade 1983; Rassi, Rassi et al. 2010). The progressive destruction of 
cardiac fibers and the intense fibrosis from replacement of dead myocytes can 
cause heart failure and ventricular arrhythmias (Rassi, Rassi et al. 2000). 
Chronic Chagas gastrointestinal disease is caused by the destruction of 
intramural autonomic ganglia, which can have impact on esophagus, colon, or 
both (Rassi, Rassi et al. 2000; Rassi, Rassi et al. 2010).  
 
1.1.3.3 Progression and Clinical manifestations 
1.1.3.3.1 Acute phase 
The progression of Chagas disease has been characterized into three distinct 
developmental stages: acute phase, indeterminate phase and chronic phase 




lasts for 4-8 weeks. Patients at acute stage are usually asymptomatic and most 
of them are not aware of the infection (Rassi, Rassi et al. 2010). When symptoms 
occur they include: malaise, fever, swelling of lymph nodes and tissues. In the 
case of vector-borne transmission, the signs of portal of entry of T .cruzi include 
subcutaneous oedema through the skin or via the ocular mucous membranes, 
which is referred to as Romaña’s sign. Death occurs in less than 5-10% of 
symptomatic cases at this stage, most of which result from myocarditis or 
meningoencephalitis or both(Rassi, Rassi et al. 2010).  At acute stage, high 
blood parasitaemia is detected and every nucleated cell in the host is a target of 
infection. Antiparasitic drugs, such as benznidazole and nifurtimox, can usually 
cure acute infection and prevent chronic manifestations (Voigt, Bock et al. 1972; 
Masana, de Toranzo et al. 1983; Pinto, Ferreira et al. 2009). Even without the 
intervention of trypanocidal drugs, the acute infection can spontaneously 
resolves in about 90% of infected individuals.   
 
1.1.3.3.2 Indeterminate phase 
Approximately 60-70% of patients with acute Chagas disease will never develop 
clinically apparent disease and remain in the indeterminate phase for life. This 
phase is characterized by positive serology, low level of parasitaemia, normal 
electrocardiogram (ECG) and no abnormality of organs (Macedo 1999). 
Sanchez-Gullen’s work has shown that the concentration of superoxide 
dismutase (SOD) were significantly elevated in patients in the indeterminate 




response in the inhibition of inflammation after infection (Perez-Fuentes, Torres-
Rasgado et al. 2008). A recent study has reported that cardiac mitochondria are 
involved in the genesis and progression to chronic chagasic cardiopathy despite 
the ‘silent’ state of the phase when the host- pathogen equilibrium is altered 
(Baez, Lo Presti et al. 2013).  
 
1.1.3.3.3 Chronic phase 
About 30-40% of patients with infection of T. cruzi will develop a determinate 
form of chronic Chagas disease (Lescure, Le Loup et al. 2010; Rassi, Rassi et al. 
2010). Typical clinical manifestations are associated with heart, colon, 
esophagus, or a combination and can be grouped into three categories: cardiac, 
digestive and cardiodigestive (Rassi, Rassi et al. 2000; Tarleton 2003). The 
cardiac form is the most serious manifestation of the chronic phase and about 
20-30% of the chronic patients will develop into this form. Common symptoms 
include enlargement of heart, bradyarrhythmias and tachyarrhythmias, 
abnormalities of the conduction system, apical aneurysms, and 
thromboembolism (Marin Neto, Simoes et al. 1999; Ribeiro, Nunes et al. 2012). 
Cardiac failure is often a late manifestation and chagasic cardiomyopathy is the 
most common cause of death during the chronic phase of Chagas in South 
America. Accounting for nearly 70% of all deaths, sudden death is the main 
reason of death, followed by refractory heat failure and thromboembolism (Rassi, 
Rassi et al. 2001). Patients who were asymptomatic may suffer from sudden 




referred to as “megasyndromes”, in the form of dilation of the gastrointestinal 
tract (megaesophagus and megacolon), combined with weight loss and 
swallowing difficulties.  Patients with megacolon can also present chronic 
constipation, abdominal pain, volvulus, obstructions, and intestinal 
perforations(Garcia, Aranha et al. 2003). Amastigotic cysts can damage 
ganglionic neurons in the digestive system thus reducing the ability of smooth 
muscle to dilate and contract and causing a loss of muscle control. The 
parasympathetic denervation is another characteristic of chronic Chagas disease 
(Tostes, Bertulucci Rocha-Rodrigues et al. 2005).  
 
1.1.3.4 Prevention, diagnostics and treatment 
1.1.3.4.1 Prevention 
Currently prevention of Chagas disease only relies on vector control and 
prevention of transmission from non-vectorial mechanisms (Rassi, Rassi et al. 
2010; Quijano-Hernandez and Dumonteil 2011). Vector eradication programs, 
including chemical control of the vector by conventional spray or by community 
participation during the surveillance phase, have been launched in a number of 
Central and South American countries such as Argentina, Belize, Bolivia, Brazil, 
Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, 
Nicaragua, Panama, Peru, Uruguay and Venezuela (Schofield and Dujardin 
1997). Combined with compulsory screening of blood donors, continuous health 




considerably reduced disease incidence and prevalence has been observed in 
most Latin America countries participated in the program (Rojas de Arias, Ferro 
et al. 1999; Moncayo 2003; Gurtler, Kitron et al. 2007).  Nonetheless, control of 
the disease still requires adequate attention and efforts. Several challenges 
remains as a number of insect vectors have shown difficulty to control and the 
possibility of resurgence of vector-borne transmission in regions once 
successfully controlled still exists. The effect of insecticides can last no more 
than 1 year, so control interventions have to be repeated at a regular basis 
(Oliveira Filho 1999; Vazquez-Prokopec, Spillmann et al. 2009).  
 
Currently there is no vaccine available for Chagas disease, although efforts have 
been made in the development of T. cruzi vaccines (Quijano-Hernandez and 
Dumonteil 2011). A very limited variety of T. cruzi antigens have been evaluated 
so far, and some studies have focused on the identification of novel antigens. A 
growing consensus has pointed out that a successful vaccine will need to induce 
a strong immune response, which requires the stimulation of Th1 immune profile 
with the activation of CD8+ cytotoxic T cells in order to effectively control T. cruzi 
parasites (Zapata-Estrella, Hummel-Newell et al. 2006). Recent studies have 
shown that several vaccines types, including recombinant proteins, DNA and 
viral vectors, as well as heterologous prime-boost combinations, can be 
immunogenic and protective in mouse models, which provides first-hand data on 
the feasibility of a preventive and/or therapeutic vaccine to control the parasite 




Lorena, Lorena et al. 2010). However, many challenges remain to be addressed, 
including technical, ethical and logistical issues. A major concern with Chagas 
disease has been the damage caused by vaccination, which may stimulate 
autoimmunity and induce exacerbation rather than protection (Kierszenbaum 
1999; Tarleton and Zhang 1999).  This has considerably slowed down vaccine 
research. Another major issue is the design of clinical trials. The course of 
Chagas disease can be 20-30 years. The trials would need to take place for at 
least 20 years to observe any significant effect (Camargo 2009). In addition, 
given the low incidence of disease in some countries, randomized controlled 
trials may need a large number of volunteers (Quijano-Hernandez and Dumonteil 
2011). The lack of widely accepted biomarkers to evaluate vaccine efficacy can 
be another problem in the development of T. cruzi vaccines (Ndao, Spithill et al. 
2010).  
 
1.1.3.4.2 Diagnostics and treatment 
At the early stage of infection with T. cruzi, trypomastigotes may be detected in 
the bloodstream by direct microscopic observation in blood or by various culture 
techniques (WHO 2002; Gomes, Lorena et al. 2009). Unfortunately, acute 
Chagas disease are often undetected because most of the patients are 
asymptomatic or only have mild and unspecific symptoms. Once the immune 
response initiates, parasitaemia is scarce and detection of parasites becomes 
very difficult (Dubner, Schapachnik et al. 2008). At the chronic phase, the 




least two different serological techniques based on different principles and 
detecting different antigens to conclude diagnosis, according to the 
recommendation from World Health Organization (WHO) (WHO 2002; 2005; 
Rassi, Rassi et al. 2010). In the case of ambiguous and inconsistent results, a 
third technique should be used. Conventional serological methods include 
primarily immunofluorescence assays (IFA), enzyme-linked immune sorbent 
assays (ELISA) and indirect hemagglutination assays (IHA) (Afonso, Ebell et al. 
2012). A recent review of eighteen studies and 61 assays of the diagnostic 
serological assays of Chagas disease pointed out that the sensitivity and 
specificity of the serological diagnostic assays appear less accurate than 
previously thought, only 90% and 98% respectively (Afonso, Ebell et al. 2012).  
 
The aim of treatment is to eradicate the parasite and alleviate the symptoms of 
the disease (Rassi, Rassi et al. 2010). Since the 1960s, the only drugs with 
proven efficacy against Chagas diseases are, nifurtimox (Nfx) and benznidazole 
(Bz).  Nfx is a nitrofurane and Bz is a nitroimidazole compound. Nfx targets the 
nitroreductase in the parasite, which generates a nitroanion leading to the 
formation of reactive nitrogen species that T. cruzi fails to remove (Wegner and 
Rohwedder 1972). Bz can create a covalent bond with various parasite 
components and inhibits the reduction-oxidation processes in T. cruzi (Masana, 
de Toranzo et al. 1983; Perez-Molina, Perez-Ayala et al. 2009). The use of these 
drugs to treat the acute phase of the disease is widely accepted, but not for the 




effects, frequently forcing the physician to stop treatment. The most common 
adverse effects of Nfx are: anorexia, loss of weight, psychic alterations, 
excitability, sleepiness, digestive manifestations such as nausea and diarrhea. In 
the case of Bz, skin manifestations are the most frequent, including 
hypersensitivity, dermatitis, and generalized oedema, with depression of bone 
marrow, thrombocytopenic purpura and agranulocytosis being the more severe 
manifestations. Toxicity tests with Nfx indicated neurotoxicity, testicular damage, 
ovarian toxicity, and deleterious effects in adrenal, colon, esophageal and 
mammary tissue. Deleterious effects of Bz were observed in adrenals, colon and 
esophagus. In addition, the metabolism of several xenobiotics biotransformed by 
the cytochrome P450 system can be inhibited by Bz. Studies have pointed out 
that both drugs exhibited mutagenic effects and can be tumorigenic or 
carcinogenic (Castro, de Mecca et al. 2006). Bz is usually used as first line option 
because of its better safety and efficacy profile. Antitrypanosomal treatment is 
strongly recommended for all cases of acute, and reactivated infection and for 
both children and adult patients. By contrast, it should not be offered to patients 
with severe Chagas heart symptoms or megaesophagus with swallowing 
difficulties. Treatment for patients at the chronic phase of Chagas disease usually 







1.2 The Genome of T. cruzi  
The T. cruzi genome project started in the 1990s when a group of laboratories 
began to collect clone libraries, EST sequences and a few initial shorter genome 
sequences for the selected reference strain CL Brener. The strain was selected 
based on its clinical and laboratory characteristics: (1) it was isolated from 
domiciliary vector Triatoma infestans; (2) its infectivity in mice was well studied; 
(3) it prefers to invade smooth muscle cells; (4)it demonstrated a clear acute 
phase post invasion; (5) it was susceptible to current antiparasitic drugs 
(Zingales, Pereira et al. 1997; Teixeira, de Paiva et al. 2012). In 2005, the 
genome sequence of T. cruzi CL Brener was published, in parallel with the 
sequences of Trypanosoma brucei and Leishmania major (Berriman, Ghedin et 
al. 2005; El-Sayed, Myler et al. 2005; Ivens, Peacock et al. 2005). The project 
applied both a clone-by-clone strategy and a whole genome shotgun strategy, 
because of the high repeat content and hybrid nature of the genome. Based on 
the comparison of contigs with a low-coverage genome sequence that produced 
from the Esmeraldo genome, a parental strain of CL Brener belonging to T. cruzi 
IIb subgroup, they successfully distinguished reads of the two distinct haplotypes, 
named Esmeraldo-like and non-Esmeraldo-like.  The genome was established by 
5489 scaffolds (containing 8740 contigs), totaling 67Mb (El-Sayed, Myler et al. 
2005). Based on the assembly results, the diploid genome was estimated to be 
approximately 110 Mbp in size. The G+C content of the entire genome is 51%. A 
total of 22,570 open reading frames (ORFs) were identified for both haplotypes, 




10368 from either one. 3590 pseudogenes were also identified. The mean length 
of coding DNA sequence (CDS) is 1513 bp with a median value of 1152bp. The 
G+C content of the CDS region (53.4%) is significantly higher, compared to that 
of the inter-CDS region (47%), consistent with what has been reported to other 
systems as well, such as C. elegans and D. melanogaster (Zhang, Kasif et al. 
2004; El-Sayed, Myler et al. 2005). Protein-coding genes were arranged as long 
polycistronic unit on the same DNA strand. Approximately half of the CDSs 
identified, no function could be assigned on the basis of significant similarity to 
previously characterized proteins or functional domains. One interesting finding 
from the genome analysis is the high degree of synteny between the two 
haplotypes with differences in intergenic and subtelomeric regions or 
amplification of repetitive sequences.  
 
More than half of the T. cruzi genome consists of repetitive regions, consisting 
large gene families of surface antigens, retrotransposons and subtelomeric 
regions. Most chromosomes consist of core regions containing multiple 
polycistronic transcription units (PTU)(Liang, Haritan et al. 2003). The core 
regions are surrounded by the large repeated regions. Occasionally 
subtelomeric-like regions can occur inside core regions in a chromosome, 
probably caused by fusion of chromosomes. The regions between polycistronic 
units are referred to as strand-switch regions (SSR). Depending on the 
transcriptional orientation, the units can be convergent (transcriptional operons 




(transcriptional operons start on opposite strands of the SSRs and diverge from 
one another) (Riou and Yot 1977; Liang, Haritan et al. 2003; Ouellette and 
Papadopoulou 2009). The length of SSR varies from 100bp to 10kb. Convergent 
SSRs are found to be potential transcription termination sites, while divergent 
SSRs are usually associated with transcription initiation.  
 
In 2009, the majority of the contigs and scaffolds were assembled into pairs of 
homologous chromosomes on the basis of predicted parental haplotype, 
inference from TriTryp synteny maps and the end sequences from T. cruzi 
bacterial artificial chromosome (BAC) libraries (Weatherly, Boehlke et al. 2009). 
A total of 41 pairs of chromosomes were assembled, in agreement with the 
predicted number of T. cruzi chromosomes based on pulse field gel analysis 
(Figure 3). Over 90% of annotated genes were included in the assembly of 
chromosomes. The majority of genes excluded from the chromosomes belong to 
multi-gene families, as the repetitive nature of those genes made accurate 
position almost impossible (Weatherly, Boehlke et al. 2009). 
 
In addition to investigations of the nuclear genome, several studies have 
examined the mitochondrial genome of kinetoplastid which contains interlocked 
DNA rings known as kinetoplast DNA (kDNA) (Brener 1973; Simpson 1973). In 
T. cruzi, a kDNA network consists of thousands of minicircles 0.5-10 kb in size 
and dozens of maxicircles 20-40 kb in size. In vivo, kDNAs condense into a disk-





Figure 3 Chromosome assembly of T. cruzi.  
A Model of assembled chromosomes represent the consensus view of both 
“Esmeraldo-like” and “non-Esmeraldo-like” haplotypes, since CL Brener 
reference strain is a hybrid of both lineages. Gene family members are depicted 





eukaryotes, encode rRNAs and several proteins involved in energy transduction. 
As with other trypanosomatid mitochondrial genes, sequence analysis has 
reported that frameshift errors were observed in most genes on T. cruzi 
maxicircles and can be corrected at the RNA level by a complex uridine (U)-
insertion/deletion process known as RNA editing (Hajduk, Harris et al. 1993). The 
information necessary for the proper insertion/deletion is present as small 
mitochondrial guide RNAs (gRNAs) encoded mainly by minicircles with a few 
exceptions encoded by maxicircles. The gRNAs covalently joined to the 3ʹ end of 
an mRNA and undertake U insertion or deletion by editosome machinery (Stuart 
and Panigrahi 2002). The sequence of the 25kb T. cruzi maxicircles have 18 
tightly clustered mitochondrial protein-coding genes and two rRNA genes, which 
are syntenic with those in T. brucei and Leishmania tarentolae. Comparative 
analyses of the mitochondrial genomes of different strains of T. cruzi revealed 
that outside the coding region existed strain-specific repetitive regions which 
enable researchers to examine phylogenetic relationships between different 





1.3 Genetic diversity of T. cruzi   
The population of T. cruzi is highly heterogeneous and consists of a large 
number of strains with distinctive characteristics with regards to morphology, 
growth, virulence, pathogenesis, antigenic profile, metacyclogenesis, tissue 
tropism, and responses to drugs. For example, the digestive form of chronic 
Chagas disease is observed almost exclusively south of the Amazon basin 
(including Argentina, Brazil, Chile and Bolivia) and is only sporadic in northern 
South America, Central America, and Mexico. This geographical difference was 
contributed to the strain difference of T. cruzi in these areas (Miles, Feliciangeli et 
al. 2003; Campbell, Westenberger et al. 2004; Rassi, Rassi et al. 2010).  In 1999, 
a consensus regarding the strains of T. cruzi was reached and two major 
lineages were identified: T. cruzi I and T. cruzi II. The T. cruzi I lineage 
predominates in the sylvatic transmission cycle and is less resistant to 
trypanocidal drugs. The T. cruzi II lineage predominates in the domestic 
environment and are characterized by their drug resistance. The T. cruzi II was 
further subdivided into five discrete typing units (DTUs): IIa, IIb, IIc, IId, and IIe. 
Phylogenetic analysis of the T. cruzi strains indicated the existence of the third 
major group of T. cruzi population. In 2009, six distinct DTUs were reported 
based on an international consensus: T. cruzi I-VI (Table 1). Commonly used 
experimental strains are scattered among the DTUs: Sylvio X10 (I), Y (IIb), CL 






Table 1 Classifications of T. cruzi strains.  
 





Two hybridization events define the population structure of T. cruzi (Figure 4). In 
the first one, a fusion between ancestral DTU I and IIb strains gave rise to a 
heterozygous hybrid that later homogenized its genome to become the 
homozygous progenitor of DTUs IIa and IIc. In the second event, the 
hybridization between DTU IIb and IIc strains and generated DTUs IId and IIe 
introduced extensive heterozygosity with subsequent recombination of parental 
genotypes (Westenberger, Barnabe et al. 2005). 
 
Comparative genomics between different T. cruzi strains has been done between 
the Sylvio X10 clone from TcI DTU and CL Brener (Franzen, Ochaya et al. 2011). 
The Sylvio X10 genome (~ 44 Mbp per haploid genome) is considerably smaller 
than that of CL Brener (~55 Mbp per haploid genome) (Andersson 2011; 
Franzen, Ochaya et al. 2011). The genome synteny and gene identity are highly 
conserved with very limited differences noted in the core gene content between 
the two, however, 6 open reading frames were reported missing in Sylvio X10 
(Franzen, Ochaya et al. 2011). The genetic diversity between the two stains is 
significant: 77,349 nucleotide differences and 1,861 insertion-deletion were 
identified in CDSs, 19% of which were associated with critical amino acid 
changes. Many large multigene families in Sylvio have fewer copies, compared 
to CL Brener, including MASP, glycoprotein 63 (GP 63), DGF, and mucin, which 
account for 50% of the size difference between the two strains. The repertoires of 
surface molecule genes are very divergent as well (Franzen, Ochaya et al. 





Figure 4 Two hybridization events define the population structure of T. 
cruzi.  
The schema of the evolutionary history of T. cruzi subgroups highlighted two 
hybridization events: one between ancient Type 1 and Type 2; the other between 
DTU IIc and DTU IIb. The inheritance of maxicircles from parental donors is 
indicated by open circles and dotted lines. Based on the maxicircles, T. cruzi 
strains were categorized into three clades, which were color coded by yellow, 







Figure 5 Comparison of gene content for some of the largest gene families 
between Sylvio X10 and CL Brener strain of T. cruzi. 
Gene content of selected multigene faimilies were expressed as the percentage 
of genome and were label next to the bars. The yellow markings indicated the 
number of genes for each family in the annotated CL Brener. The gene families 
are: dispersed gene family 1 (DGF), trans-sialidases, mucins, glycoprotein 63 
(GP 63), mucin-associated surface proteins (MASP), recombination hot spot 
(RHS), 90 kDa protein family (90), kinesin (one subfamily), mucin-like 




It has been reported that the non-coding portion of maxicircles have strain-
specific repetitive areas and a variable region that is unique in each strain with 
the exception of a conserved sequence motif that may serve as the start site of 
replication (Westenberger, Cerqueira et al. 2006). Previous studies have noticed 
uniparental maxicircle inheritance with in vitro crosses of T. cruzi strains (Gibson, 
Crow et al. 1997; Gaunt, Yeo et al. 2003). So it is not surprising that maxicircle 
sequences have been used as taxonomic markers in the population genetics and 
evolution analysis of T. cruzi. Three major clades of maxicircles have been 
identified from 45 T. cruzi strains including six defined DTUs (Machado and 
Ayala 2001; Flores-Lopez and Machado 2011). T. cruzi Y and Esmeraldo strains 
represent clade C, while CL Brener belongs to clade B. Integrating with the 
model of T. cruzi hybridization events, it has been proposed that clade B evolved 
from a clade A maxicircle passed by the common ancestor of DTU IIa/IIc strains 
after the DTU I and DTU IIb hybridization event (Brisse, Henriksson et al. 2003) 
(Figure 4). The clade B maxicircle was then inherited by DTU IId/IIe hybrids from 
their DTU IIc ancestor. Phylogenetic analysis of several loci on the maxicircles 
have confirmed the closer association of clade B with clade A than clade C, 
supporting the uniparental inheritance of DTU IIa/IIc maxicircles from DTU I 
strain (Westenberger, Cerqueira et al. 2006). 
 
Since Chagas disease presents in a diversity of clinical forms, these studies can 
contribute to the understanding of genetic variation and their correlation with 




for the selection of potential drug targets and antigenic candidates for better 
diagnosis and vaccine development. For instance, strains belonging to T. cruzi II, 
and the hybrid V and VI are the most virulent ones. Comparisons between the 
above strains and non-virulent strains may help identify an interesting gene list 
that are disease-causing (Lima, Lenzi et al. 1995). However, the degree to which 
the genomic variations are associated with strain differences in host preference 







1.4 Gene expression in trypanosomes 
Unlike other eukaryotes, T. cruzi genes in coding for proteins with unrelated 
functions are organized into co-directional clusters that undergo polycistronic 
transcription by RNA polymerase II (Pol II) (El-Sayed, Myler et al. 2005; Siegel, 
Tan et al. 2005). Most chromosomes contain at least two polycistronic gene 
clusters, which can be either divergently or convergently transcribed (Weatherly, 
Boehlke et al. 2009). Transcription initiates from divergent strand-switch regions 
(SSRs) and terminates at convergent SSRs, where tRNA genes are often located 
(although they can be present at non-SSRs) (Ouellette and Papadopoulou 2009; 
Siegel, Hekstra et al. 2009). Recent chromatin immunoprecipitation and 
sequencing (ChIP-seq) experiments examining the distribution of chromatin 
components in other trypanosomes revealed that histone post-translational 
modifications can direct the regulation of transcription and play a crucial role in 
polycistronic transcription initiation and termination (Siegel, Hekstra et al. 2009). 
Destabilization of nucleosomes by histone variants is an evolutionarily ancient 
and general mechanism of transcription initiation.  
 
Trans-splicing, together with polyadenylation, allows polycistronic transcripts to 
be processed into monocistronic units ready for translation (El-Sayed, Myler et al. 
2005; Daniels, Gull et al. 2010)(Figure 6). In the mini exon region, or the splice 
leader locus, each gene possesses a Pol II promoter region. During trans-
splicing event, a 39-nt splice leader sequence is transferred from SL RNA to the 




Liang, Haritan et al. 2003). The signal of trans-splicing events has been reported 
as an AG dinucleotide and a polypyrimidine tract of varying length upstream of it 
(Michaeli 2011). Trans-splicing events are spatially and temporally coordinated 
with the polyadenylation events (LeBowitz, Smith et al. 1993; Matthews, Tschudi 
et al. 1994). There is no consensus polyadenylation signal in the 3′ UTR. Instead, 
evidence from a small number of loci in related trypanosome species T. brucei 
has suggested a preference usage of polyadenylation sites around adenines 
(Benz, Nilsson et al. 2005). However, no such analysis has been done for T. 
cruzi. Current knowledge suggests that trypanosomatids lack precise 
transcriptional control because no classical promoters have been identified 
(Siegel, Gunasekera et al. 2011). Regulation of gene expression is mainly at the 
post-transcriptional level, and it has been proposed to occur through pre-mRNA 
processing, RNA degradation, or translational repression (Martinez-Calvillo, 
Vizuet-de-Rueda et al. 2010). Both the 5′ UTR and 3′ UTR can be involved in 
stabilization-destabilization mechanisms, up-regulating and down-regulating 
mRNA levels in a developmentally regulated manner. Heterogeneity of RNA 
processing sites, present as alternative trans-splicing and polyadenylation sites, 
have been detected at high frequency across the genome in T. brucei and T. 
vivax, but in C. elegans, of which the trans-splicing events are common, the 
frequency of alternative trans-splicing is much lower (Hirsh and Huang 1990; 
Graber, Salisbury et al. 2007). The significance of this phenomena and their 
possible roles in the posttranscriptional regulation has not been fully investigated 





Figure 6 Gene expression in trypanosomatids. 
Large clusters of genes coding unrelated functions are organized into 
polycistronic units (PTU), designated by rectangles in different color. 
Transcription start sites (TSS), indicated by the arrow on transcript, are usually 
located upstream of the first gene of the PTU. The premature polycistronic RNA 
is transcribed by RNA pol II, and is cleaved into individual RNAs by the coupled 
trans-splicing and polyadenylation reactions. A 39-nt splice leader sequence will 
be added to the 5ʹ end of each individual RNA (blue rectangular), whereas a 
poly(A) tail will be added to the 3ʹ end, represented by AAAA. The cap in the 





1.5 Comparative genomics of trypanosomes 
The publication of genomic sequences of Trypanosoma brucei (Berriman, 
Ghedin et al. 2005), Trypanosoma cruzi (El-Sayed, Myler et al. 2005) and 
Leishmania major (Ivens, Peacock et al. 2005)provided a foundation for 
researchers to investigate the similarity and differences of these parasites at the 
genomic scale and understand their distinctive adaptation strategies in different 
host environments. T. brucei and L. major are the etiologic agents of sleeping 
sickness (African trypanosomiasis) and leishmaniasis, respectively. These 
trypanosomes are hemoflagellates of the family Trypanosomatidae belonging to 
the order Kinetoplastida and are characterized by the presence of a single 
flagellum and kinetoplast, which contains mitochondrion. Each parasite has a 
complex life cycle involving both human host and insect vectors: T. cruzi, a 
triatomine bug, also known as the “kissing bug”; T. brucei, a blood-sucking fly, 
known as the tsetse fly; L. major, a phlebotomine sandfly. Both T. cruzi and L. 
major are intracellular parasites, but T. cruzi have the capacity to invade various 
nucleated host cells while L. major usually targets macrophages. T. brucei is an 
extracellular parasite and can rapidly manipulate their membrane proteins and 
escape the attack from host immune responses.   
 
Comparative genomic analysis provided interesting insights in the genetic and 
evolutionary facts that may explain the distinct and shared characteristics of the 
parasites. Strikingly, large-scale highly conserved synteny between the three 




200 to 500 million years ago, indicating strong selective pressure of the gene 
order and orientation.  An ‘‘all-versus-all’’ basic local alignment search tool 
(BLASTP) comparison of the predicted protein sequences within each of the 
three genomes was made to cluster closely related paralogous genes. The 
mutual best BLASTP hits between the three proteomes were grouped as clusters 
of orthologous genes (COGs). Approximately 6,200 genes were identified as 
three-way COGs, also known as the Tritryp core, presenting an interesting gene 
list of potential drug targets against the three diseases at the same time (Figure 
7). About 2,000 out of the 6200 genes do not have any orthologs in human host, 
making chemotherapeutic intervention even more feasible. Almost all genes in 
the Tritryp core are located in regions of conserved synteny. Approximately 40% 
of the synteny breakpoints are associated with expansions of multi-gene families, 
retroelements, and/or structural RNAs, which also has been observed in 
mammalian systems (Gimelli, Pujana et al. 2003; Bailey, Baertsch et al. 2004). 
Marked difference in gene size and density between the three trypanosomes is 
significant. The average length of CDSs in L. major is substantially longer than 
that of T. cruzi and T. brucei. Since the boundaries of transcripts were not 
defined by the time this comparison analysis took place, the authors pointed out 
the different inter-CDS length between Tritryps: L. major has the longest one, 
twice that in T. brucei and three times that in T. cruzi. Consequently, T. cruzi has 
the highest gene density of the three. Amino acid sequence alignment of the 
three-way COGs revealed an average 57% identity between T. cruzi and T. 




consistent with expected phylogenetic relationships. In addition, the comparative 
genomic analysis identified species-specific gene clusters encoding proteins 
responsible for unique form of each disease and different survival strategies 








Figure 7 Comparative genomics of Tritryps.  
(A) Conserved synteny was observed between the genomes of Tritryps. Synteny 
breaks are located mainly in subtelomeric region. (Red: Leishmania major, 
Purple: Trypanosome brucei, Blue: Trypanosome cruzi) (B) A Venn diagram of 
distribution of genes among the kinetoplastid parasites, calculated with the use of 




1.6 RNA sequencing technology  
Over the past decade, expression microarray is the most widely used 
methodology for transcriptome analysis, but it is approaching its technical limits 
including dye-based hybridization and cross hybridization artifacts. In addition, it 
cannot detect any new genes besides the predicted ones. Microarray technology 
can only measure expression levels within a certain range, due to noises 
produced by non-specific cross-hybridization, saturation, spot density and quality. 
Also, comparison between different experiments can be very difficult and may 
require complex statistical methods. (Euskirchen, Rozowsky et al. 2007; Bloom, 
Khan et al. 2009; Fu, Fu et al. 2009; Bradford, Hey et al. 2010; Griffith, Griffith et 
al. 2010). The above issues have made it difficult for standard array designs to 
provide an accurate and comprehensive detection for transcriptome, especially 
for T. cruzi of which genome has relatively low variation and less steady state 
mRNA (Minning, Weatherly et al. 2009). RNA-Seq as a recently developed 
technology is an optimum solution since large scale high-throughput mRNA 
sequencing can reveal exclusive details of expression profile and transcription 
pattern for T. cruzi in its life stages. It can also be used in reconstructing full 
length transcripts, correcting 3ʹ and 5ʹ UTRs, detecting novel genes and genomic 
variation at the nucleotide or transcript level. (Cloonan and Grimmond 2008; 
Marioni, Mason et al. 2008; Mortazavi, Williams et al. 2008; Pepke, Wold et al. 
2009; Wang, Gerstein et al. 2009; Griffith, Griffith et al. 2010; Wilhelm, Marguerat 







Figure 8 Overview of a typical RNA-Seq experiment.  
Long RNAs are converted into cDNA libraries by either RNA fragmentation or 
DNA fragmentation. Sequencing adaptors are added to the ends of each cDNA 
fragments. One or both ends of the DNA fragment are sequenced on high-
throughput parallel sequencing platform. Subsequently, the obtained reads are 




The library construction protocol has been optimized for RNA-Seq experiments in 
trypanosomes when the aim of study is to capture the RNA processing events 
(Figure 9). Both ends of the transcripts can be enriched by taking advantage of  
the unique splice leader sequence at the 5ʹ end of trypanosome RNA or the 
poly(A) tail at the 3ʹ end (Kolev, Franklin et al. 2010; Mulindwa, Fadda et al. 
2014). First-strand cDNA synthesis is generated with random hexamers or 
oligo(dT) primers, then second strand cDNA can be reverse transcribed with SL-
specific primers. A clear preference for the 5ʹ end and 3ʹ end of transcripts were 
noted. Similar method has also been proposed for the enrichment of parasite 
RNA from a pool of RNAs from both host and pathogen. However, distortion of 
transcriptomic profiles have been reported in the latter case (Mulindwa, Fadda et 
al. 2014). So unless the main purpose of RNA-Seq is the characterization of RNA 
processing sites, random priming should be applied in library construction, 
instead of SL-specific priming.  
 
The pipeline for a typical RNA-Seq differential expression (DE) analysis is 
outlined in Figure 10. First, reads are aligned to the reference genome or 
transcriptome. Second, the number of reads mapped to each feature (gene, 
exon, junction or transcript) are summarized into a count table. Next, the gene 
table of counts will be normalized followed by statistical testing of DE. The 
resulting output is usually a ranked list of genes with P value or fold changes. 
Finally, biological insight from the differentially expressed genes can be obtained 





Figure 9 Outline of an end-enriched RNA-Seq experiment for 
trypanosomes. 
To capture more reads that are generated from the 5ʹ end of the mRNAs, an SL-
specific primer can be used for the synthesis of the second strand of cDNA (blue 
texts). To capture more reads that generated from the 3ʹ end of the mRNAs, an 
oligo(dT) primer can be used for the synthesis of the first strand of cDNA (red 






Figure 10 A general overview of the pipeline of RNA-Seq analysis for 
detecting differential expressed genes.  
Red boxes describe the steps applied in the pipeline; blue boxes display the 
methodological components and software examples of the pipeline. Major 
processes of differential expression analysis include mapping of reads to 
reference genome, summarization, normalization, DE statistical testing, and 




1.7 Summary of dissertation work 
The long-term goal of this project was to understand the biology of the human 
parasite Trypanosoma cruzi across different developmental stages of its life 
cycle, characterize the host-pathogen interaction, and contribute to the 
identification of potential drug targets. T. cruzi is a kinetoplastid parasite with a 
very complex life cycle involving both human host and insect vector. Our work 
here included two major components: the first part is the characterization of RNA 
processing events in T. cruzi developmental stages pre- and post-infection of 
human host cells; the second is simultaneous interrogation of the transcriptome 
of the human pathogen Trypanosoma cruzi and its infected host cell. 
 
The publication of the genome sequence of T. cruzi CL Brener in 2005 
represents a major advance that has contributed to the understanding of the 
biology of the Chagas disease parasite (El-Sayed, Myler et al. 2005). Yet a 
systematic genome-wide identification of transcripts has not been conducted for 
T. cruzi and a major challenge remains to identify the bona fide transcripts and 
the exact boundaries of the transcripts. Unlike other eukaryotes, trypanosome 
genes coding for proteins with unrelated functions are organized into co-
directional clusters that undergo polycistronic transcription by RNA polymerase II 
(Pol II)(El-Sayed, Myler et al. 2005; Siegel, Tan et al. 2005; Siegel, Gunasekera 
et al. 2011). Trans-splicing, together with polyadenylation, allows polycistronic 
transcripts to be processed into monocistronic units ready for translation (Sutton 




Daniels, Gull et al. 2010). The lack of identifiable RNA pol II promoters in 
trypanosomatids suggests that these organisms lack precise transcriptional 
control over the majority of their genes (Siegel, Gunasekera et al. 2011). Thus, 
regulation of gene expression occurs mainly at the post-transcriptional level, 
through pre-mRNA processing, RNA degradation, or translational repression 
(Martinez-Calvillo, Vizuet-de-Rueda et al. 2010). Both the 5′ UTR and 3′ UTR can 
be involved in stabilization-destabilization mechanisms, up-regulating and down-
regulating mRNA levels in a developmentally regulated manner. Heterogeneity of 
RNA processing sites, present as alternative trans-splicing and polyadenylation 
sites, have been detected at high frequency across the genome in T. brucei and 
T. vivax. The significance of this phenomena and its potential role in 
posttranscriptional regulation has not been fully investigated (Kolev, Franklin et 
al. 2010; Greif, de Leon et al. 2013). In our current study, we have generated the 
first complete transcriptome map for Trypanosoma cruzi with the next generation 
RNA sequencing technology (RNA-Seq). The analysis documented in Chapter 2 
focused on the characterization of RNA processing events across different 
developmental stages of T. cruzi. We mapped transcribed regions at single 
nucleotide resolution on a genomic scale, retrieved trans-splicing and 
polyadenylation sites for T. cruzi across various developmental stages, and 
enhanced and curated the current genome annotation. In addition, with the 
unprecedented resolution of transcriptome, we discovered the prevalent 
heterogeneity of RNA processing sites across the genome.  The preference of 




presents as a potential and interesting approach for posttranscriptional 
regulation. 
 
Great efforts have been made in the understanding of interactions between the 
Chagas disease parasite and human host.  However, little is known about the 
strategies exploited by the pathogen during the infection process. In this study, 
we present the transcriptomes of three main T. cruzi life cycle stages including 
the simultaneous capture of host and parasite transcriptomes in an intracellular 
infection time course in vitro. Using the T. cruzi and human genome sequence as 
scaffolds, we explored these data with informatics tools to identify genes with 
significant regulation and successfully profiled gene expressions from both 
species simultaneously.  The present study compares the steady state 
transcriptomes of three main life cycle stages of T. cruzi: (1) tissue culture-
derived trypomastigotes: non-dividing, tissue penetrating forms;  (2) intracellular 
stages up to and including replicating amastigotes; and (3) axenically-grown 
epimastigotes which correspond to the replicating insect vector stage of the 
parasite. A comparison of steady state transcriptomes revealed a significant 
number of differentially expressed genes between distinct life cycle stages of the 
parasite, reflective of their divergent biology. Distinct signatures of gene 
expression are observed as the motile invasive forms of T. cruzi transition into 
non-motile replicative forms in mammalian host cells. Gene Ontology (GO) 
enrichment of K-means clusters revealed the function associations between 




genes identified consensus regulatory elements as potential binding sites for 
trans-acting factors. In addition, we simultaneously captured changes in the 
steady state transcriptome of infected human host cells and identified many 
significantly regulated genes detected in human host throughout the infection 








Trypanosoma cruzi is the etiological agent of Chagas disease, which is ranked 
as one of the most important pathogens throughout Central and South America. 
In spite of the intensive investigation and rigorous medical control initiatives over 
the past decades, Chagas disease remains a significant danger to human health. 
Currently no vaccine is available and treatments are limited and toxic. In this 
study, we generated the first complete transcriptome map for Trypanosoma cruzi 
and infected human host cells with the next generation RNA sequencing 
technology (RNA-Seq). We conducted a systematic characterization of bona fide 
transcripts and genomic structures, which can provide a fundamental and 
important framework for the better understanding of both transcriptional and 
posttranscriptional regulation mechanisms in the pathogen. The identification of 
differentially expressed genes from both the parasite and host across different 
time points of the infection process as well as distinctively regulated genes in T. 
cruzi at its extracellular stages will help elucidate the survival strategy of the 
parasite applied at various environments, the defense response from the human 
host post invasion, as well as the biology of host-pathogen interaction. This 
knowledge can eventually contribute to the development of effective medical 
intervention, the improvement of public health in the developing countries where 







Chapter 2: RNA Processing Events in T. cruzi Developmental 
Stages Pre- and Post-Infection of Human Host Cells 
2.1 Objective of Study 
Unlike the majority of eukaryotes, typical transcription unit of the parasite T. cruzi 
does not have a classical promoter region and protein-coding genes with 
unrelated functions are organized into co-directional clusters that undergo 
polycistronic transcription by RNA polymerase II (Pol II). Despite the remarkable 
progress in the sequencing of trypanosomatid genomes, we still do not have a 
good understanding of the RNA processing events. Various genomic structure 
components, including UTRs, polypyrimidine tract, acceptor sequence, as well as 
intergenic regions, were not annotated in T. cruzi. In this study, we aim to 
construct the transcriptome of T. cruzi at single nucleotide resolution, 
characterize the RNA processing events across its different developmental 
stages (trypomastigote, epimastigote, and amastigote), as well as enhance and 
curate the current genome structure annotation. 
2.2 Materials and Methods 
2.2.1 Materials 
Trypanosoma cruzi Y strain (Silva 1953) was cultivated by weekly passage in 
LLcMK2 cells (ATCC®CCL-7) in Dulbecco’s modified Eagle medium (DMEM) 
with 2% fetal bovine serum (FBS), 2 mM L-glutamine, 10 mM HEPES and 




from the pelleted culture supernatants of infected LLcMK2 (1,000g for 10 
minutes) after a 2-4 hour incubation at 37oC, 5% CO2 to allow the motile 
trypomastigotes to swim away from the pellet. Human foreskin fibroblasts  (HFF) 
(ATCC®CRL-2522) were seeded in complete DMEM (as above, with 10% FBS) 
in 10 cm2 plates or T-25 flasks with a glass coverslip and grown for 48 hours prior 
to infection with T. cruzi Y strain trypomastigotes for 2h, washed 5 times with 
PBS, and incubated in complete media. At the indicated time points (4-72 hpi), 
cells were rinsed with PBS and the coverslip removed and fixed in 4% 
paraformaldehyde/PBS. Epimastigote forms of T. cruzi were grown axenically in 
liver infusion tryptose medium at 27oC.     
 
2.2.2 Methods 
Alignment of Spliced Leader (SL) reads and 5ʹ UTR analysis 
Sequences were pooled from biological replicates for each time point (4 hr, 6 hr, 
12hr, 24 hr, 48 hr, 72 hr, trypomastigote and epimastigote). The 5ʹ end of all 
reads were searched for the presence of at least 10 nucleotides from the 3ʹ end 
of the SL sequence using the ʹgrepʹ function in Linux. The identified SL-
containing reads and their respective paired mates were extracted for further 
analysis. Detected SL nucleotides (ranging from 10-39) were removed from the 
SL-containing read. Tophat (v2.0.6) was used to map the remaining portion of 
the SL-containing reads and their respective paired reads to the T. cruzi CL 
Brener reference genome Esmeraldo haplotype (El-Sayed, Myler et al. 2005; 




allowed and multireads (reads that can be mapped to multiple loci) were mapped 
to the site with best alignment score. The coordinates and sequences of coding 
regions (CDS) were downloaded from TriTrypDB, version 4.1 (www.tritryps.org). 
For each instance where the SL-containing read occurred between two 
consecutive annotated CDSs, the alignment coordinates of the non-SL portion of 
the SL-containing read was used to retrieve the exact location of the trans-
splicing site. The length of the 5ʹ UTR was defined as the distance between the 
trans-splicing site and the start of the CDS. All sequence manipulations, trans-
splicing and 5ʹ UTR site analysis were performed using in-house Python or Linux 
shell scripts. For instances where the SL-containing read occurred inside 
annotated CDSs, the alignment coordinates of the non-SL portion of the SL-
containing read were also collected as an additional dataset. Data visualization 
was carried out on R platform (Team 2008) with plotting packages ggplot2 
installed (Wickham 2009). 
 
Alignment of poly(T)-containing reads and 3ʹ UTR analysis 
Sequences were pooled from biological replicates for each time point (4 hr, 6 hr, 
12hr, 24 hr, 48 hr, 72 hr, trypomastigote and epimastigote). The 5ʹ end of all 
reads were searched for the presence of at least 5 nucleotides of thymidine using 
the ʹegrepʹ function in Linux. The reason we chose to focus on poly(T)-containing 
reads, instead of poly(A)-containing reads was due to the fragment size of the 
cDNA library and the orientation of sequencing. Because the average fragment 
size was around 300bp and the reads were 101 bp, sequenced from 5ʹ to 3ʹ of 




of the fragment is very small unless the fragment size is much smaller 200 nt. On 
the contrary, its paired mate can be detected containing the poly(T) sequence at 
its 5ʹ end. The identified poly(T)-containing reads and their respective paired 
mates were extracted for further analysis. Detected thymidine nucleotides were 
removed from the poly(T)-containing read. Tophat (v. 2.0.6)  was used to map 
the remaining portion of the poly(T)-containing reads and their respective paired 
reads to the T. cruzi CL Brener reference genome Esmeraldo haplotype .A 
maximum of two mismatches per read were allowed and multireads (reads that 
can be mapped to multiple loci) were allowed to map to up to 20 locus. We 
applied a relatively less stringent strategy when mapping poly(T) reads in the 
polyadenylation analysis because we want to capture as many polyadenylation 
sites as possible at the initial steps as the number of poly(T) reads were much 
lower than SL-containing reads and depended on criteria described below to 
ensure the confidence of sites detected . For each instance where the poly(T)-
containing read occurred between two consecutive annotated CDSs and the 
number of thymidines removed from the poly(T)-containing read exceeds the 
number of adenines in the genome at the same loci, the alignment coordinates of 
the non-poly(T) portion of the poly(T)-containing read was used to retrieve the 
exact location of the polyadenylation site. The length of the 3ʹ UTR was defined 
as the distance between the polyadenylation site and the end of the CDS. All 
sequence manipulation, polyadenylation 3ʹ UTR site analysis were performed 
using in-house Python or Linux shell scripts. Data visualization was carried out 





Alternative Start Site and Missing ORFs analysis 
All 5ʹ UTRs longer than 20 nt were scanned to identify potentially extended open 
reading frames. Alternative start codon(s) inside the 5ʹ UTRs were detected if 
they were upstream and in-frame with the currently annotated start codon. The 
scanning and detection steps were performed using in-house Python scripts. 
 
If 1) a 5ʹ UTR or 3ʹ UTR contained both a start codon and an in-frame stop codon 
and 2) the newly identified ORF was greater than 180 nt, then a potential missing 
ORFs was tagged. Novel ORFs were further selected from the pool by meeting 
the minimum coverage standard: the sum of reads across all samples mapped to 
the region had to be more than the number of samples n (here n=10). Novel 
ORFs with both trans-splicing and polyadenylation sites detected were further 
selected. All ORF-containing UTRs were removed from our gene structure 
analysis. The function and orthology of newly identified ORFs were further 
investigated by querying the RefSeq protein database [The NCBI handbook 
[Internet]. Bethesda (MD): National Library of Medicine (US), National Center for 
Biotechnology Information; 2002 Oct. Chapter 18, The Reference Sequence 
(RefSeq) Project] with NCBI BLASTX algorithm (Gish and States 1993). The top 
hit of each query were outputted.  Of all the novel ORFs, potential GPI-anchored 
proteins were predicted by FragAnchor software (Poisson, Chauve et al. 2007) 
[website: http://navet.ics.hawaii.edu/~fraganchor/NNHMM/NNHMM.html], 
proteins with potential trans-membrane domains were predicted by software 




predicted by SignalP v4.1 (Petersen, Brunak et al. 2011). Putative domains were 
identified by searches against the Conserved Domain Database (CDD) 
(Marchler-Bauer, Zheng et al. 2013).  
 
Alternative splicing analysis 
The trans-splicing site with the largest number of SL-containing reads mapped 
was defined as primary. Alternative splicing events were identified for each of the 
developmental stages and pooled together for some of the analyses. We focused 
our analysis on the developmental stages of trypomastigote, epimastigote, and 
amastigotes 72 hr post invasion because the number of SL-containing reads 
were significantly higher in these three stages. Primary trans-splicing sites with 
less than three reads mapped were filtered out in the downstream analysis.  In 
order to capture genes with dominant usage of the primary site, we selected 
genes with a ratio of number of reads mapped to the primary site over the 
number of reads mapped to the secondary site greater than 1.6 (P/S > 1.6) at all 
three stages. We generated next a gene list by selecting genes that displayed a 
switch in the primary trans-splicing site between any two of the three 
developmental stages and with secondary sites at least 20 nt away from the 
primary site. Similar analysis were also conducted for secondary sites at least 50, 
100, and 200 nt away from primary trans-splicing sites. 
 




The splice acceptor site was identified for each gene by extracting the 
dinucleotide sequence in the genome upstream of the detected trans-splicing 
site. The sequence composition of the region spanning 90 nt upstream and 10 nt 
downstream of the trans-splicing sites, including both primary and minor sites, 
was plotted using WebLogo, version 3.3 (Crooks, Hon et al. 2004). 
 
Polypyrimidine tract characterization 
A window of 250 nt upstream of the primary trans-splicing site was scanned to 
identify polypyrimidine (polyPy) tracts. A polyPy tract was defined as the longest 
stretch of sequence consisting of pyrimidines, allowing interruption by no more 
than a single purine. The length of the polyPy tract, the distance between the 3ʹ 
end of the polyPy tract and the trans-splicing site and the distance between the 3ʹ 
end of the pyrimidine tract and the polyadenylation site were computed. The 
nucleotide composition of the polyPy tract was visualized by WebLogo, 
version.3.3 (Crooks, Hon et al. 2004). 
 
Alternative polyadenylation analysis 
The polyadenylation site with the largest number of poly(T)-containing reads 
mapped was defined as primary. Alternative polyadenylation events were 






2.3 Results  
Experimental samples interrogated using RNA-Seq 
We applied an RNA sequencing approach to characterize the global 
transcriptome of the T. cruzi (Y strain) parasite across various time points in its 
life cycle. Those included two extracellular forms (epimastigote and 
trypomastigote) and the intracellular forms (amastigotes) at 4, 6, 12, 24, 48 and 
72 hrs post-invasion of human foreskin fibroblasts (HFFs) cells. In vitro infection 
experiments were repeated on different dates and for each of the developmental 
stages, we collected sequence data from two to four independent biological 
replicates, generating a total of 1.35 billion pairs of 100 bp reads from 34 
samples (Table 7, see appendix). Because the goal of this component of our 
study was to characterize the gene structure in T. cruzi, only ~400 million reads 











 T. cruzi 
(millions) 
SL-containing reads  
Poly(A) containing 
reads  
Extracellular 0 276 1.07% 0.27% 
Intracellular 1,963 122 1.38% 0.28% 






Characterization of transcript boundaries and gene structure elements 
related to RNA processing 
The significance of defining distinct transcript boundaries and gene structure 
regulatory elements for each of the 10,343 T. cruzi genes is of particular 
relevance to the biology of this pathogen which, like other trypanosomatids, lacks 
transcriptional control of its polycistronic gene clusters. We exploited two mRNA 
sequence features (trans-splicing of a mini-exon sequence and polyadenylation) 
to accurately map the 5′ and 3′ boundaries of genes. We selected subsets of 
reads that ended with at least a 10-nt match to the 3′ portion of the spliced leader 
(SL) sequence or at least five thymine residues. A total of 4,631,345 SL-
containing and 1,055,377 poly(T)-containing reads were identified, respectively 
1.16% and 0.27% of the reads that can be mapped to T. cruzi reference genome 
(Table 2)(Tables 6, and 7, see appendix). Trimming of the SL and poly(T) 
sequences and mapping the remaining tags back to the genome allowed us to 
identify at least one SL-addition site for 7,869 distinct genes (76% of annotated 
total) and at least one polyadenylation site for 6,311 distinct genes (61%) in one 
or more of the developmental stages. When we increase our mapping stringency 
by requiring at least three SL-containing or poly(T)-containing reads to assign the 
primary site for each feature, the number SL-addition site detected decreased to 
7,203 distinct genes (70% of annotated total) and the number of polyadenylation 
sites detected decreased to 3,108 distinct genes (30%). This is consistent with 
the observation above showing a lower proportion of T. cruzi poly(T)-containing 




by documented library construction artifacts causing under-representation of 
poly(A) segments.  We report the coordinates of all putative SL-addition and 
polyadenylation sites detected in this study in relation to the existing T. cruzi 
gene structure annotation in TriTrypDB (Tables S2, S3, see appendix). 
 
Using the coordinates of the SL-addition sites and existing start codon 
annotations for coding sequences (CDS), we defined the boundaries of all 5′ 
UTRs in the T. cruzi genome. The median 5′ UTR length was 68 nt with a range 
from 1 nt, right abutting the initiation codon, to 2029 nt (Figure 11A).The 39-nt 
SL sequence was not included in the 5′ UTR length calculation. The distribution 
of the 5′ UTR lengths was similar across different life stages of the parasite 
(Figure 12). A similar analysis using poly(A) addition sites and existing stop 
codon annotations allowed us to determine the boundaries of the 3′ UTRs. The 3ʹ 
UTR length distribution was tighter than observed for the 5ʹ UTRs, with a median 
length of 197 and a range from 1 to 4362 nt (Figures 11B, 13). A careful 
examination of the annotation of genes in the upper and lower quartiles of both 5ʹ 
and 3ʹ UTR length distributions revealed no enrichment in any particular 
functional category (Table S4). The median mRNA length was 1402 nt, of which 
the 5′ UTR, CDS, and 3′ UTR accounted for 5%, 81%, and 14%, respectively. No 
significant correlation was noted between CDS length and either UTR length or 
between corresponding UTR lengths (Figure 14). With the gene boundaries 
accurately mapped for the first time in T. cruzi, we were able to define the 
intergenic regions. The median value for intergenic spacing was 166 nt (Figure 




splicing sites were located within the range of 100 to 200nt downstream of the 
polyadenylation site. This may point to an optimal distance for the concerted 
action of the trans-splicing and polyadenylation machineries (LeBowitz, Smith et 






Figure 11 Length and position distribution of various gene structure 
components in T. cruzi.  
(A) Distribution of the lengths of 5′ UTRs. A Spliced Leader (SL) analysis of reads 
obtained from all developmental stages was performed to map the exact trans-
splicing site associated with each CDS and to identify the coordinates and 
lengths of the 5′ UTRs. Alternative splicing events were included in the analysis 




length greater than 2 kbs were not included in the plot. (B).Distribution of the 
lengths of 3′ UTRs. A polyadenylation site analysis of sequences from all 
developmental stages was performed to map the poly(A) addition site associated 
with each CDS and to identify the coordinates and lengths of the 3′ UTRs as 
described in Methods.  Alternative polyadenylation events were included in this 
analysis. All 3′ UTRs containing newly identified ORFs were excluded. Three 
genes with 3′ UTR length greater than 3 kbases were not included in the plot. 
(D).Distribution of novel and annotated CDS lengths. Start and stop coordinates 
for coding sequences were retrieved for the T. cruzi CL Brener reference 
genome - Esmeraldo haplotype (TriTrypDB, version 4.1), and CDS lengths 
computed.  Black indicated the distribution of CDS length computed from the 
current annotation. Red bars are CDS length from the novel ORFs identified in 
this study. Partial CDSs were excluded along with a small percentage (3.78%) of 
ORFs in the current annotation from TriTrypDB (v4.1) with no clear translation 
frames defined. A window of 250 nt upstream of the primary trans-splicing site 
was scanned to identify polypyrimidine (polyPy) tracts. The lengths of the polyPy 
tracts (C), distance between the 3′ end of the polyPy tract and the trans-splicing 
site (E) and the distance between the 3′ end of the polyPy and the 
polyadenylation site (F) were binned in length intervals and plotted. (G) Size 
distribution of intergenic regions. Intergenic regions were mapped between the 
primary polyadenylation site and the primary trans-splicing site of the 






Figure 12 Distribution of the lengths of 5′ UTRs in transcript expressed in 
different developmental stages of T. cruzi. 
A Spliced Leader (SL) analysis of reads obtained from each of the three 
developmental stages was performed to map the exact trans-splicing site 
associated with each CDS and to identify the coordinates and lengths of the 5′ 
UTR. Results are shown for (A) trypomastigotes, (B) epimastigotes, and (C) 
intracellular amastigotes (72 hpi). Alternative splicing events were included in the 
analysis and 5′ UTRs containing newly identified ORFs were not. A total of three 






Figure 13 Distribution of the lengths of 3′ UTRs in transcripts expressed in 
different developmental stages of T. cruzi. 
A polyadenylation site analysis of sequences from each of the three 
developmental stages was performed to map the poly(A) addition site associated 
with each CDS and identify the coordinates and lengths of the 3′ UTR 




Trypomastigotes, (B) Epimastigotes, and (C) amasitgotes 72hpi.  Alternative 
polyadenylation events were included in this analysis. All 3′ UTRs containing 
newly identified ORFs were excluded. A total of three genes with 3′ UTR length 






Figure 14 Correlations between CDS length and either UTR length or 
between corresponding UTR lengths. 
 (A) The correlation between the length of 5′ UTR and CDSs. (B) The correlation 
between the length of 3′ UTR and CDSs. (C) The correlation between the length 
of 5′ UTR and 3′ UTR. The value of Pearson correlation (r) was labeled in the 














5' UTR 68 131 152 1 2029 
PolyPy tract 23 25 30 3 93 
Distance between 
TS and polyPy 
47 75 127 1 242 
3' UTR 197 263 355 1 4362 
Distance between 
poly(A) and polyPy 
127 206 430 1 5887 
CDS 1137 1503 1884 69 16764 
Distance between 
downstream splice 
addition site and 
upstream poly(A) 
166 240 409 1 5840 




We extended our analysis to include the examination of features known to be 
involved in the regulation of RNA processing events. Polypyrimidine (polyPy) 
tracts are located upstream of the 3ʹ splice acceptor sites and provide a required 
signal for the trans-splicing machinery (Huang and Van der Ploeg 1991; Siegel, 
Tan et al. 2005; Gunzl 2010). We searched for the longest stretch of pyrimidine 
residues, interrupted by no more than two contiguous purines and located 
upstream of each of the primary trans-splicing sites. PolyPy tracts ranged from 3 
to 93 nt in length, with a median value of 23 nt (Figure 11C) and a clear usage 
preference for thymine (72.47 %) over cytosine (23.7%) residues. This 
observation is consistent with the findings in T. brucei and T. vivax (Kolev, 
Franklin et al. 2010; Greif, de Leon et al. 2013) and our logo analysis shown in 
Figure 18F. The distance between the polyPy tract and the upstream primary 
polyadenylation site exhibited a relatively tight distribution with a median value of 
127 nt (Figure 11F), which was twice the median distance (47 nt) between 
polyPy tract and the downstream primary SL-addition site (Figure 11E). This 
spacing of the polyPy tract about two thirds of intergenic regions can also be 
noted in T. brucei (Kolev, Franklin et al. 2010). The investigation of extreme 
values in each genomic components identified in this analysis did not reveal an 
obvious function or gene copy bias (Table S4, see appendix).  
 
With the canonical features for the T. cruzi genes resolved at the single 
nucleotide level, we compared them to their orthologous elements reported in T. 




shorter median length of the 5′ and 3′ UTR regions in T. cruzi genes when 
compared to T. brucei (Figure 15). To account for possible biases from species-
specific multigene families, we further restricted our analysis to the subset of 
syntenic three-way clusters of orthologous genes (COGs) in the reference 
trypanosomatid (TriTryp) genomes (El-Sayed, Myler et al. 2005) and obtained 
similar results (Figure 16, Table 3). This relative compaction of the T. cruzi 
UTRs is congruous with earlier observations we made at the level of coding 
sequences, whereby the mean length of CDS regions in T. cruzi was markedly 
shorter than in T. brucei (Kolev, Franklin et al. 2010). We have updated here our 
computation of mean CDS lengths in T. cruzi using a more recent version of the 
genome annotation and report the results in Figure 11D. Despite the fact that T. 
cruzi has a notably smaller genes (CDS + UTRs), our characterization here of the 
true intergenic region (and not the inter-CDS region) reveals longer intergenic 
regions in T. cruzi when compared to T. brucei. We infer that the higher gene 
density in the T. cruzi genome is directly the result of shorter UTR lengths. 
We noted that the GC content of CDS is the highest (53.02%), followed by 5′ 
UTR (45.83%) and intergenic regions (42.44%), with the lowest level detected in 








Figure 15 Comparison of gene structure components between T. cruzi and 
T. brucei. 
The median length of each gene structure components of T. cruzi were 
compared with what has been reported in T. brucei (Kolev, Franklin et al. 2010). 







Figure 16 Distribution of UTR lengths for T. cruzi and T. brucei genes in 3-
way COGs. 
(A)The length of 5ʹ UTRs for genes belonging to the three-way COGs were 
included in the analysis. In comparison, the lengths of 5ʹ UTRs from T. brucei 
transcripts (Kolev, Franklin et al. 2010) that also belong to the three-way COGs 
were plotted in the inset. (B) The length distribution of 3ʹ UTRs for T. cruzi and T. 






Table 4 GC content of different gene structure components in T. cruzi. 
Nucleotide 5′ UTR CDS 3′ UTR 
Intergenic 
region Genome 
G 26.97% 29.29% 23.71% 23.24% 25.19% 
C 18.86% 23.73% 17.55% 19.20% 25.19% 
A 29.61% 23.55% 26.53% 20.75% 24.77% 
T 24.56% 23.43% 32.10% 34.60% 24.85% 
GC 






Novel ORFs and revised ORF boundaries 
The transcriptional evidence dataset we have generated here provided us with 
an opportunity to revisit our gene calls. We identified 834 novel ORFs present in 
trans-spliced and polyadenylated transcripts and not originating within previously 
annotated CDSs (Tables S5, S6, and S7). The median size of the newly 
identified ORFs was small (294 nt, Figure 11D) and expected since small ORFs 
with no evidence of expression were systematically excluded during the early 
gene predictions (El-Sayed, Myler et al. 2005). We examined the novel ORFs for 
sequence homology in RefSeq and the Conserved Domain Databases, and 
annotated them for features such as predicted signal peptides, transmembrane 
domains and GPI anchors. The novel ORFs were not particularly enriched for 
any of the attributes examined: 7.4% contained a sequence with homology to a 
known protein domain/superfamily, 9.7% were predicted to contain a signal 
peptide, 4.7% may represent GPI-anchored proteins and 36.1% contained 
putative transmembrane domains (Table S7). Of the 399 novel ORFs with 
database matches, a great majority (89%) had high levels of identity (E-value 
<10-5) to T. cruzi hypothetical proteins. 
 
We also conducted a genome-wide search across all 5′ UTRs to identify the 
potential for extended CDS regions. We detected 5,480 putative alternative in-
frame start codons upstream of the existing start codon coordinate (Table S8). 
Validation of the start site(s) used for translation initiation will likely emerge soon, 





Alternative RNA processing sites  
The sequencing depth of our transcriptome profiling experiments allowed not 
only the identification of the SL-addition and polyadenylation sites at a single-
base resolution, but also the characterization of widespread alternative RNA 
processing events in T. cruzi. Because our study design was mainly aimed at a 
quantitatively unbiased profiling of the transcriptome of the parasite at various 
developmental stages, we did not enrich for SL- or polyA-containing reads during 
library construction and relied on deep coverage to collect relatively large 
numbers of reads from both ends of transcripts (6.4 million SL- and 1.1 million 
polyA-containing reads). This approach permitted us to identify as well as 
quantitate differential RNA processing events (Figure 17). 
 
Of the 7,869 genes with SL-addition sites detected, 88% used more than one 
trans-splicing site in at least one developmental stage (42% used two to four 
trans-splicing sites and 46% had greater than 5 sites). This observation is similar 
to what has been reported for T. brucei where 89% of genes showed evidence of 
alternative trans-splicing events (Kolev, Franklin et al. 2010). An examination of 
the trans-splicing sites revealed a propensity for usage of the canonical acceptor 
sequence (AG) both at the primary (95%) and minor (33%) splicing sites 
(Figures 18A, 18B, 19; Table S9, see appendix). The distribution of the 







Figure 17 An example of alternative trans-splicing events. 
The mapping coverage from all reads and SL-containing reads of gene 
Tc00.1047053504929.5 are visualized as tracks on Integrative Genomics Viewer 
(IGV). The red region indicates the CDS region. Two distinctive trans-splicing 








Figure 18 Sequence composition at RNA processing sites and distance 
between primary and alternative RNA processing sites. 
Spliced leader acceptor sites were retrieved by extracting the dinucleotide 
upstream of each detected trans-splicing site. The frequency of dinucleotide 
usage was determined for primary (A) and alternative (B) acceptor sites. The 
sequence composition of the region encompassing 90 nt upstream and 10 nt 
downstream of the trans-splicing sites was plotted for the primary (F) and 
alternative (Figure 19) splice sites using WebLogo (Crooks, Hon et al. 2004). 




for splicing sites applying AG (C) and non-AG (D). Alternative SL trans-splicing 
events were identified for each of the developmental stages and pooled for this 
analysis. The distance between the primary trans-splicing site and alternative 
trans-splicing sites is positive in value when the alternative trans-splicing site(s) 
are located upstream of the primary site and negative when the alternative trans-
splicing site(s) are located downstream of the primary site. (E) Distribution of the 
distances between primary and alternative polyadenylation sites. Alternative 
polyadenylation events were identified for each of the developmental stages and 
pooled together for this analysis. The distance between the primary and the 
alternative poly(A) addition site(s) is positive in value when the alternative poly(A) 
addition site(s) was located upstream of the primary site and negative when the 
alternative poly(A) addition site(s) was located downstream of the primary site. A 
similar analysis was performed with transcripts derived from trypomastigotes, 
epimastigotes, and amastigotes 72hpi. The sequence composition of the region 
encompassing 50 nt upstream and 50 nt downstream of the primary poly(A) 
addition site was plotted for the primary (G) and alternative (Figure 20) poly(A) 







Figure 19 Analysis of sequence composition at alternative spliced leader 
acceptor sites. 
Spliced leader acceptor sites were retrieved by extracting the dinucleotide upstream 
of each detected trans-splicing site. The sequence composition of the region 
encompassing 90 nt upstream and 10 nt downstream of the alternative trans-splicing 





Figure 20 Analysis of sequence composition near the minor 
polyadenylation sites. 
The sequence composition of the region encompassing 50 nt upstream and 50 nt 






acceptor sequence revealed that a great majority (84%) of the alternative splice 
sites are located downstream of the primary site (Figure 18C). This observation 
is consistent with a model that proposes that the 3ʹ splice site in mammalian 
introns is located by a scanning process that recognizes the first AG downstream 
of the branch point in a sequence-specific context (Mount 1983; Smith, Porro et 
al. 1989). In fact, we note a significant effect based on the nucleotide preceding 
the AG, whereby CAG and UAG account for 50% at the primary splice site in 
contrast to 37% at the downstream alternative sites (37%), further supporting a 
previous model that proposes that the combination of proximity and competition 
influences the selection of the primary splice site (Table 5) (Mount 1983).  
 
The usage of non-canonical acceptor sequences was much more pronounced in 
the alternative (67%) than in the primary (5%) splice sites (Figures 18A, 18B). 
Unlike for the canonical acceptor sequences, the distribution of the distances 
between the primary and the alternative non-AG splicing sites was 
heterogeneous and showed no distinct pattern, with the exception of a peak of 
alternative trans-splicing events that occurred within the 10 nt that precede the 
primary site (Figure 18D). A similar peak can be observed for AG splicing sites, 
albeit less pronounced. Those peaks may reflect sloppy splicing events near the 
primary SL-addition site as has been suggested previously for T. brucei (Kolev, 
Franklin et al. 2010; Siegel, Hekstra et al. 2010) and/or slippage due to the 
presence of tandem NAGNAG acceptors. We also noted a slight preference for 




We are unable to rule out polymorphisms between the strain used in this study 
(strain Y) and the reference genome (CL Brener) as a source, at least in part, of 
this bias as well as some of the non-canonical sites we observe. A sequence 
composition analysis of the region immediately upstream of the SL-addition 
events allowed us to visualize the intervening polypyrimidine tract between the 






Table 5 Usage frequency of nucleotide proceeding splicing acceptor (AG) 
site.  





C(AG) 21% 20% 20% 
U(AG) 29% 17% 19% 
A(AG) 31% 42% 22% 





A significant proportion (28%; 16,911) of alternative SL-addition sites we have 
identified fall within the annotated CDS regions, reflecting two possible scenarios: 
misannotated initiation start sites or events that have the potential to impact the 
resulting protein product(s) (Table S10, see appendix). An example of the latter 
is the gene encoding LYT1 (Tc00.1047053503829.50), for which we detected 
two alternative SL-addition sites at positions -46 and +10 relative to the start 
codon (+1) (Figure 25A). T. cruzi LYT1 has been reported to generate two 
protein products, a process mediated through stage-regulated alternative trans-
splicing events (Manning-Cela, Gonzalez et al. 2002). The shorter product (28 
amino acid truncation) localizes to the mitochondrial kinetoflagellar zone, 
whereas the longer product localizes on the plasma membrane (Benabdellah, 
Gonzalez-Rey et al. 2007). 
 
Of the 6,311 genes for which polyadenylation sites were identified, 3,988 use an 
alternative polyadenylation site in one or more developmental stages, 62% of 
which used two to four polyadenylation sites and 38% used more than four sites. 
The heterogeneity observed is similar to what we have calculated for T. brucei 
where 92% of genes display evidence for alternative polyadenylation events 
(Kolev, Franklin et al. 2010). The distribution of the distances between primary 
and alternative polyadenylation sites revealed that ~75% of the minor sites were 
located within a 200 nt window centered around the primary site, whereas 27% 




heterogeneity of polyadenylation sites at several closely spaced positions has 
been observed not only in T. brucei  (Matthews, Tschudi et al. 1994; Benz, 
Nilsson et al. 2005; Kolev, Franklin et al. 2010) but also in other systems, 
including plants, animals and human (Elkon, Ugalde et al. 2013; Ji, Guan et al. 
2014). While no consensus motif such as the AAUAAA required for cleavage and 
polyadenylation in higher eukaryotes was present upstream of the 
polyadenylation site, we noted a strong U(A/G)(A/G) motif abutting the Poly(A)+ 
addition site for the primary and alternative polyadenylation sites alike (Figures 






Figure 21 Distribution of distances between primary and alternative 
polyadenylation sites in transcripts from different developmental stages of 
T. cruzi. 
 Alternative polyadenylation events were identified for each of the developmental 
stages. The distance between the primary polyadenylation site and alternative 
polyadenylation sites is positive in value when the alternative polyadenylation 
site(s) was located upstream of the primary site and negative when the 
alternative polyadenylation site(s) was located downstream of the primary site. 
Results are shown for (A) trypomastigotes, (B) epimastigotes, and (C) 




Alternative trans-splicing events across parasite development 
The heterogeneity of RNA processing that we detected at high frequency in the 
form of alternative trans-splicing and polyadenylation events may be the 
manifestation of another level of gene expression regulation. To examine the role 
and dynamics of RNA processing events at different stages of the development 
of the parasite, we examined the usage of alternative SL-addition sites in the 
three stages where our coverage of the transcriptome was deep. Those included 
reads from the trypomastigote, epimastigote and amastigote 72 hpi samples, 
which in total, constituted 78% of the SL-containing reads. The remaining 22% 
included the combined reads from amastigotes at several time points in the 
range of 4-72 hpi. 
 
In order to identify a subset of genes that switch the use of their primary trans-
splicing site across different stages, we calculated the ratio of number of reads 
mapping to the primary site over the number of reads mapping to the secondary 
site (P/S) and plotted that ratio against the number of reads mapped to the 
primary site. The P/S ratio provided a measure of the preferential usage of the 
primary site, with increasing values denoting dominance of the primary site, and 
the number of reads mapping to the primary site was used as a surrogate for 
expression level (and indirectly confidence in the significance of the ratios) 
(Figures 22A, 23). This approach allowed us to visualize potentially interesting 
subsets of genes with high expression levels in trypomastigotes and a 






Figure 22 Alternative splicing profiles of T. cruzi trypomastigote, 
amastigote and epimastigote stages. 
(A) Analysis of the usage of primary and secondary trans-splicing sites in 
trypomastigotes in context of expression across developmental stages.  For each 
gene where alternative splicing events were identified, the ratio of  SL-containing 
reads mapping to the primary site over the secondary site (P/S)  was plotted 
against the number of SL-containing reads mapping to the primary site (P) in the 
trypomastigote stage (shown here) and in the epimastigote and amastigote (72 




switch between the reference stage shown and at least one of the other 2 stages. 
(B) Selection of genes with primary trans-splicing sites switching across 
developmental stages with coverage, primary site usage, and distance between 
alternative sites successive constraints. (C) Switching of primary spliced leader 
addition site across developmental stages. The ratio of SL-containing reads 
mapping to the primary site over the secondary site (P/S) was plotted for genes 
that switched primary site between any two of the three developmental stages 
and with more than three reads mapped to the primary sites in all three 
developmental stages. Red dots represent genes with P/S ratio greater than 1.6 








Figure 23 Analysis of the usage of primary and secondary trans-splicing 
sites in epimastigotes and amastigotes (72 hpi) in context of expression 
across developmental stages. 
For each gene where alternative splicing events were identified, the ratio of  SL-
containing reads mapping to the primary site over the secondary site (P/S)  was 
plotted against the number of SL-containing reads mapping to the primary site 
normalized by the total number of SL-containing reads at that stage (P) for (A) 
epimastigote and (B) amastigote (72 hpi) stages. Red dots represent genes that 
display a primary site switch between the reference stage shown and at least one 







highlight genes that underwent primary site switching in the epimastigote and 
amastigote (72 hpi) stages (labeled in red in Figure 22A). We repeated this 
analysis using each of the two other stages (epimastigotes and 72 hpi 
amastigotes) (Figure 23). 
 
We further refined the list by carrying out sub-selections based on multiple 
criteria. We first reduced the 6,941 distinct genes which display alternative trans-
splicing sites in at least one of the developmental stages to 4,874 by retaining 
genes that had a minimum of 4 reads mapping to the primary trans-splicing site 
in each of the three stages and therefore relatively weaker evidence for switching 
events (Figure 22B). Limiting our subset to genes with a P/S ratio > 1.6 in all 
three life stages further reduced the number to 4,076 genes. For genes that 
underwent primary site switching across developmental stages, we further 
investigated the dominance of the primary sites by visualizing the P/S ratio in a 
three dimensional space with each axis representing one of the three stages 
(Figure 22C). This illustration identifies a set of 198 genes (yellow spheres) that 
switched SL-addition sites between any two life stages, and highlights a subset 
locating in the outer periphery because of the high P/S value. Of those 198 genes 
that switched SL-addition sites between any two life stages, 40 were separated 
by a distance greater than 20 nt (Figure 22B and Tables S11, S12, see 
appendix). Among this subset of 40 genes, 27 and 11 displayed alternative SL-
addition events separated by a distance greater than 50 nt and 200 nt, 




events that seem to be under tight developmental regulation and not the result of 
a sloppy splicing machinery (Tables S11, S13). Although a Gene Set Enrichment 
Analysis (GSEA) revealed no significant overrepresentation of gene functions in 
genes with stage-regulated alternative splicing of the SL, we did note some 
striking examples of alternative splicing events across stages (Figure 24, 25). 
For example, we noted T. cruzi gene Tc00.1047053511545.130, currently 
annotated as a conserved hypothetical protein, exclusively trans-spliced at a site 
220 nt away from the start of the CDS at trypomastigote and amastigote stages 
but applied another site located approximately 150 nt away at epimastigote 
stage. Interestingly, this gene was significantly differentially regulated at 
epimastigote stage, compared to the other two developmental stages. Although 
the detailed mechanisms behind post transcriptional regulation were still not 
clear, the preference of different primary trans-splicing sites across 
developmental stages, resulting in the inclusion and exclusion of certain 
sequence elements, may influence the stability or translational efficiency of 
transcripts and present as a potential approach in the regulation of transcripts 
 
We performed similar analyses aimed at characterizing alternative 
polyadenylation events across the three developmental stages. We were unable 
to detect clear events of stage-regulated alternative polyadenylation. This may be 
due to a combination of the extensive heterogeneity of polyadenylation sites and 
the relative low coverage of poly(A)-containing reads retrieved that could be 








Figure 24 Examples of alternative trans-splicing events across 
developmental stages. 
Usage of trans-splicing sites in the trypomastigote, epimastigote and amastigote 
(72 hpi) stages is shown for (A) Tc00.1047053503899.90 (asparagine synthetase 
a, putative) and (B) Tc00.1047053511001.180 (hypothetical protein, conserved). 









Figure 25 Examples of alternative trans-splicing events across different 
developmental stages.  
Usage of trans-splicing sites in the trypomastigote, epimastigote and amastigote 
(72 hpi) stages is shown for (A) Tc00.1047053503829.50 (LYT1), (B) 
Tc00.1047053506579.50 (hypothetical protein, conserved), and (C) 
Tc00.1047053511545.130 (hypothetical protein, conserved). Primary sites are 





2.4 Conclusion and discussion 
In this study we performed deep transcriptomic surveys at eight time points in T. 
cruzi involving both intracellular and extracellular life stages. Through the use of 
ultra high-throughput sequencing technology, we mapped in the detail the 
transcriptome structure throughout its development. Unlike higher eukaryotes, 
trypanosomes do not have classic promoter regions and genes with unrelated 
functions are clustered and transcribed as long polycistronic units. Most of the 
gene expression are regulated subtly at the post-transcriptional level through 
mRNA degradation, mRNA stability and translational efficiency. However, the 
mechanisms and regulatory elements involved in these processes are still 
unclear, but in many other eukaryotes, the 5ʹ and 3ʹ UTRs contain sequence 
elements that are responsible for regulating RNA or protein synthesis. So 
characterizing the RNA processing events in T. cruzi is of great significance in 
the efforts of understanding the biology of this pathogen. Genome-wide 
investigations of gene structure have been carried out in other trypanosomes but 
not in T. cruzi (Kolev, Franklin et al. 2010; Greif, de Leon et al. 2013). In this 
study, for the first time, we systematically defined the boundaries of UTRs and 
other gene structure elements for this parasite at the genomic scale. Our work 
not only provides fundamental insights into the organization of the T. cruzi 
transcriptome, but also a framework for the integration of additional physiological 






By generating a highly resolved and calibrated transcriptome map of the 
pathogen, we characterized the mRNA processing events for more than 80% of 
the genes. A very high degree of heterogeneity of RNA processing sites were 
noted in T. cruzi. Recently, alternative trans-splicing has been discovered in 
drosophila and mammals, and in some cases has been shown to be 
physiologically significant (Horiuchi and Aigaki 2006). The degree of 
heterogeneity observed in T. cruzi was much higher than what was reported in C. 
elegans, but was comparable to other trypanosomes (Kolev, Franklin et al. 2010; 
Ramani, Calarco et al. 2011; Greif, de Leon et al. 2013). In trypanosomes, SL 
RNA trans-splicing does not necessarily contribute to proteomic diversity and 
implies a more relaxed requirement and less accurate splicing site compared to 
cis-splicing, since the SL exon is a non-coding sequence. Most surprising was 
that a large number of transcripts showed differential abundance of alternative 
splice variants across different developmental stages. More than 198 
differentially spliced transcripts were detected between amastigote 72 hpi, 
epimastigote and trypomastigote supporting the idea that alternative splicing may 
have functional consequences for the regulation of parasite survival and 
development, of which the corresponding regulatory factors remain elusive. 
Alternative splicing patterns have been observed in T. brucei during development 
as well (Nilsson, Gunasekera et al. 2010).  
 
It has been reported in trypanosomes that alternative trans-splicing is one 




Alternative trans-splicing could lead to the expression of proteins having amino-
termini of different lengths that derive from the same gene. Demonstrated by the 
group of Ochsenreiter et al., alternative trans-splicing is the approach for dual 
localization of trypanosomal isoleucyl-tRNA synthetase (IleRS) in T. brucei by 
creating a long and a short spliced variant. The protein product of the longer 
spliced variant with a presequence was targeted exclusively to mitochondria. In 
contrast, the shorter spliced variant is translated to a cytosol-specific isoform 
lacking the presequence (Rettig, Wang et al. 2012). Evidence in T. cruzi has also 
shown that, the protein encoded by LYT1 gene is involved in haemolytic activity 
at acid pH and the regulation of stage development. LYT1 gene can generate 
two protein products differing in the presence or absence of 28 amino acids at 
the end (Benabdellah, Gonzalez-Rey et al. 2007). The shorter products localizes 
in the mitochondrial kinetoflagellar zone, whereas the longer one is found on the 
plasma membrane. Our experiment captured identical alternative trans-splicing 
sites for gene LYT1 reported by Swindle’s team using PCR amplification of 
reverse transcribed mRNA in 2002. This further confirmed the accuracy and 
sensitivity of our high throughput sequencing approach. Alternative trans-splicing 
events can be an efficient mechanism for the regulation of protein 
compartmentalization. In addition, we postulate that different splice leader 
addition site at polycistronically transcribed genes can result in different stability 
or translational efficiency for each gene thus affecting protein abundance. Of all 
the genes that underwent alternative splicing events, we systematically selected 




which the reliability and dominance of the primary site were confirmed and the 
distance between primary and secondary was more than 20 nt. We propose that 
the preference of different primary trans-splicing events can be applied as a 
mechanism leading to the regulation of protein variant targeting to different 
cellular compartments.  
 
More questions can be asked with regard to the different splicing patterns: Are 
the splicing events are regulated? If yes, how does the splicing machinery adapt 
under different developmental stages? Are the resulting variants targeted to 
different cellular compartments or do they possess altered stabilities? Can the 
inclusion of some sequence motifs on the variants lead to different translational 
efficiency? The identification of potential sequence motifs located in the 5ʹ or 3ʹ 
UTRs, particularly those that will be selectively included through different splicing 
events can be very helpful in explaining the function of alternative splicing. Our 
work here provided a very interesting gene list from the pathogen that may play a 
very importance role in the survival and adaptation strategies of the parasite and 








Chapter 3: Simultaneous Interrogation of the Transcriptomes of 
the Human Pathogen Trypanosoma cruzi and its Infected Host 
Cell 
2.1 Objective of Study 
In this study, we aimed to construct the transcriptome of T. cruzi and infected 
human host cells across different time points of the infection cycle and also the 
transcriptome of T. cruzi at its extracellular stages using RNA-Seq technology. 
We sought to identify genes with significant regulation and to profile gene 
expression from both species simultaneously.  The overall goal of this chapter is 
to capture the transcriptomic signature for both pathogen and host during the 
infection cycle, characterize their adaptation strategy in different environments 
applied by the parasite and understand the biology behind it. 
 
2.2 Materials and Methods 
2.2.1 Materials 
T. cruzi (Y strain) trypomastigotes were harvested from tissue culture supernatants 
of infected LLcMK2 cells (ATCC®CCL-7) on Days 7-10 post infection as described 
(Tardieux, Webster et al. 1992). To greatly minimize contamination from amastigotes 
present in the culture supernatants (typically 5-30%) parasites were centrifuged at 
1,000g for 10 min and pelleted parasites were incubated at 37ºC for 4 hours to allow 




enriches for trypomastigotes, where 95-99% purity can be achieved as assessed by 
morphology. Epimastigotes were grown in liver infusion tryptose (LIT) at 27oC and 
harvested at mid-log phase, when metacyclics are not present.   
 
2.2.2 Methods 
RNA isolation and library construction for simultaneous transcriptome 
profiling of host and pathogen.  
RNA was isolated using Trizol® reagent, quality determined by an Agilent 2100 
bioanalyzer and quantified by qPCR using a KAPA Biosystems library quantification 
kit. Standard Illumina protocols were used for mRNA-Seq sample preparation. 
RNA-Seq libraries were constructed from polyA-enriched mRNAs of 8 T. cruzi 
developmental stages: epimastigotes, trypomastigotes, and intracellular 
amastigotes at 4, 6, 12, 24, 48 and 72 hrs post infection (hpi) of HFF cells. Libraries 
were also constructed from uninfected HFF cells at the same time points. For each 
condition, 2-4 independent biological replicates were sequenced on an Illumina 
HiSeq 1000. A total of 2.7 billion reads from 35 samples (See Table 6, 7,and 8 for 
the full experimental design) were generated from 101 bp paired-ends. 
 
Raw data pre-processing and quality trimming.  
The quality of the reads was evaluated using the FastQC tool 
[http://www.bioinformatics.babraham.ac.uk/projects/fastqc/] and one nucleotide was 
trimmed using the FastX toolkit (Hannon Lab, CSHL) when the mean of the quality 





Mapping cDNA fragments to reference genomes, abundance estimation and 
data normalization.  
Reads were aligned to the reference human genome sequence (hg19, GRCh37) 
using Tophat v2.0.8 (Trapnell, Pachter et al. 2009), allowing for two mismatches per 
read and for mapping to more than one locus). Reads were also independently 
aligned to the Esmeraldo haplotype (El-Sayed, Myler et al. 2005) of the T. cruzi CL 
Brener reference genome (v.4.1) obtained from the TriTrypDB database 
(www.tritrypdb.org) since the T. cruzi Y strain belongs to the T. cruzi Type II clade 
(Cortez, Martins et al. 2012) as the Esmeraldo parent strain. Two mismatches per 
read were allowed, however reads were allowed to map only to a single locus.The 
abundance of reads mapping to each coding sequence (CDS) was determined 
using HTSeq [http://www-huber.embl.de/users/anders/HTSeq/]. 
 
Data quality assessment by statistical sample clustering and visualization.  
Very weakly expressed genes were removed. Those were defined as having less 
than 1 read per million in n of the samples, where n is the size of the smallest group 
of replicates (Anders, McCarthy et al. 2013) (here n=2 and 3 for the T. cruzi and 
human samples, respectively). Multiple approaches were used to evaluate 
replicates and the relationships between samples across time points and to 
visualize sample-sample distances. Those included Pearson correlation and 
standardized median correlation analyses, box plots, Principal Component Analysis 




statistical pipeline, named cbcbSEQ, can be accessed on GitHub 
(https://github.com/kokrah/cbcbSEQ/) and the specific R code for the analyses is 
included in the Supplementary material section. 
 
We removed samples that did not pass the following quality assessment procedure: 
for each sample we computed the median pairwise correlation (mpc) to all other 
samples in the dataset. We then applied a standard outlier identification method to 
remove samples that have low correlation to the other samples: samples were 
removed if their median pairwise correlation (mpc) is less than Q1 (mpc) – 1.5 IQR 
(mpc) where Q1 (mpc) and IQR (mpc) are first the quartile and inter-quartile range 
of the median pairwise correlation across all samples respectively. Two samples 
from a single sequencing batch were removed as a result. 
 
Differential Expression Analysis. 
A quantile normalization scheme was applied to all samples (Bolstad, Irizarry et al. 
2003). Following log2 transformation of the data, we used Limma (a Bioconductor 
package) to conduct our differential expression analyses. Limma utilizes a standard 
variance moderated across all genes using a Bayesian model and produces p-
values with greater degrees of freedom (Smyth 2004). When appropriate, the Voom 
module was used to transform the data based on observational level weights 
derived from the mean-variance relationship (Law, Chen et al. 2014). To control for 
expression profile changes in human cells over culture, we subtracted the ‘infected’ 




the paired uninfected/infected HFF samples at each time point. Experimental batch 
effects were adjusted for by including experimental batch as a covariate in our 
statistical model (Soneson and Delorenzi 2013). To correct for Type I error rooted 
from multiple comparisons, we used q-value as the statistical parameter (Storey 
2002). A contrast matrix was used within Limma. We identified differentially 
expressed genes between infected human cells and human controls at the same 
time point, as well as between infected human cells at different time points post 
invasion. For the samples of T. cruzi, we identified differentially expressed genes 
between intracellular and extracellular stages, between the two extracellular stages 
and between different time points of intracellular stages. Differentially expressed 
genes were defined as genes with q-value < 0.05. We also generated DEG lists for 
both human and T. cruzi requiring q-value < 0.05 and fold change greater than 2.  
DEGs were also compared to published gene list from primary siRNA screening 
(Caradonna, Engel et al. 2013) and intersections were outputted as tables. 
 
K means clustering and motif analysis 
K-means clustering analysis was performed to identify genes with similar 
expression profiles across different developmental stages for both human host 
and T. cruzi with the R function “kmeans” and using the Hartigan-Wong algorithm 
(Hartigan 1979). Euclidean distance was used as distance metric; 20 partitions 
were used to generate the clusters. Quantile-normalized and batch-effect-
adjusted expression values were used for clustering. Both the 3’ and 5’UTR 




as input for XXmotif to identify potential regulatory motifs de novo (Luehr, 
Hartmann et al. 2012). We limited the motif search to a single strand with “-- 
revcomp NO” option and constrained the maximum motif size to 6 nt with “--max-
match-positions 6”. The output motifs were further examined with the 53 motifs 
identified from groups of genes with similar metabolically related functions 
reported by Frasch and colleagues. 
 
GOSeq analysis 
Significantly regulated genes in each comparison of the differential expression 
analysis and genes from each  K-mean cluster were then classified into GO 
functional categories with package GOSeq, which applied Wallenius approximation 
to correct the bias of over-detection of differential expression for long and highly 
expressed transcripts(Young, Wakefield et al. 2010). FDR is controlled by 
Benjamini and Hochberg's procedure (Benjamini and Hochberg 1995). 
 
Gene Set Enrichment Analysis (GSEA).  
Differential expression as well as k means clustering gene lists were subjected to 
Gene Set Enrichment Analysis (GSEA) (Subramanian, Tamayo et al. 2005). We 
used the pre-ranked gene tool of this Java-based software developed by Broad 
Institute. For human host, we investigated enriched gene set in both KEGG 
pathways and Gene Ontology categories from MSigDB; while for T. cruzi, we 
focused on the enriched gene set from GO database from TritrypDB.  To adjust for 




number of permutations in the test was set as 1000. We ranked the genes 
according to their fold change for the gene lists from differential expression analysis 
and chose to use weighted calculation mode assigning higher enrichment scores to 
genes on top of the list. We used the classic mode for the gene belong to the same 
cluster of k-mean cluster treating genes in the same list as equal 
 
Databases.  
The coding sequence coordinates and Gene Ontology terms for T. cruzi genes 
were also obtained from www.tritrypdb.org. The human reference genome was 
downloaded from UCSC Genome Bioinformatics database 
(http://hgdownload.cse.ucsc.edu/downloads.html), hg19 GRCh37. We used 
Molecular Signatures Databases (MSigDB) collections from Broad Institute 
(http://www.broadinstitute.org/gsea/msigdb/collections.jsp) for Gene Set enrichment 





2.4 Results  
Defining T. cruzi and human cell transcriptomes by RNA sequencing 
To capture the global transcriptional response during the initiation and 
maintenance of intracellular infection by the Chagas disease parasite, 
Trypanosoma cruzi, the transcriptomes of the parasite and infected human host 
cells were simultaneously profiled by RNA-Seq. Monolayers of low passage 
primary human foreskin fibroblasts (HFF) were infected with tissue culture-
derived trypomastigotes of the T. cruzi Y strain.  Messenger RNA was isolated 
from pure trypomastigote populations, from uninfected and infected HFF 
monolayers at 4 hrs, 6 hrs, 12 hrs, 24 hrs, 48 hrs and 72 hrs and from axenically-
grown T. cruzi epimastigotes that correspond to the replicating insect vector 
stage of the parasite (Figure 26).  RNA-Seq libraries were constructed from 
poly(A) + RNA and paired-end sequence reads of 101 nucleotides were obtained 
on the HiSeq-1500 platform. Two to four independent biological replicates were 
sequenced for each condition generating 2.7 billion high-quality reads for 34 
samples (Tables 6, 7, 8, see appendix 2). Reads that passed Illumina quality 
filters were further examined using FastQC software. The pipeline of our analysis 
is shown in Figure 27. 
 
Examination of sequenced data 
To ensure the read quality of our large scale dataset, we quantitatively examined 
the raw sequenced reads coming from high throughput sequencing pipelines. We 






Figure 26 Simultaneous interrogation of the host and pathogen 
transcriptomes - Experimental design.  
Human foreskin fibroblasts (HFF) were exposed to T. cruzi trypomastigotes (Y 
strain) for 2 hrs to permit invasion. Extracellular parasites were then removed by 
extensive washing in PBS, culture medium (DMEM+2% FBS) replaced and the 
infection allowed to progress for 72 hours at 37oC. RNA samples were collected 
at 4, 6, 12, 24, 48 and 72 hrs post invasion (hpi). Following the attachment of 
infective trypomastigotes to HFFs, they are targeted to vacuoles that have fused 




amastigotes 2-8 hpi and gradually egress into the cytoplasm (8-16 hpi). 
Amastigotes begin to replicate around 20 hpi and continue to divide, eventually 
transform back into trypomastigotes, rupturing the cell and spreading the 
infection within 96-120 hpi. Biological replicates (2 to 4) were collected for each 
of the stages of infection. Experimental and data collection details are included in 
Table S1. The pie charts indicate the proportion of sequence reads assigned to 






Figure 27 Overview of the pipeline for differential expression analysis. 
The input/output for each step of the data processing and analysis is depicted in 
rectangular boxes. Software/scripts or methodological components are shown in 
italicized blue text. Decision-making steps are represented diamond-shaped 





overview of the sequence data before doing any further analysis. The quality 
scores of each samples were examined. Out of the 34 samples, the mean quality 
score of both reads in 23 samples exceed 30 at all nucleotide positions, whereas 
the mean quality score of the last nucleotide from reads of the other 11 samples 
fell below 30 and was trimmed before downstream analysis. Two examples of 
sequencing quality score check were included in Figure 28, of which the one in 
panel B requiring trimming of the last nucleotide. The nucleotide composition of 
sequenced reads for each samples were also examined (Figure 29). In a 
random library, it is expected that little or no difference should be observed 
between different bases of a sequence run, so the lines, representing nucleotide 
composition, should be parallel and around 25% mark. However, we noticed a 
distinctive biased pattern at the first 12-14 bp of the read across all samples. 
There was an overrepresentation of sequence combination (CTNAAATCT) at the 
5ʹ end of the read. After the first 12-14 positions, the nucleotide frequencies 
became independent of position. This selection bias has been reported in other 
RNA-Seq experiments as well and is not relevant to organism or laboratory 
(Hansen, Brenner et al. 2010). This dependence of nucleotide frequency on 
position at the 5ʹ end of the read was not caused by sequencing errors but 
originated from a biased selection of random hexamer primers during the cDNA 
reverse transcription step in library construction. The extension of the pattern 
beyond the hexamer primer, out to 12 to 14 bases can probably be explained by 
the length of two hexamer primers or by the dependencies between the first 6 





Figure 28 Examples of quality scores across all bases from sequenced 
samples by FastQC.  
We examined the quality scores of sequenced reads for all sequenced samples 
and displayed two examples here. (A) HPGL0063 Read 2 and (B) HPGL0062 
Read 2. For each position, a Boxplot is drawn to visualize the quality score 
distribution. The yellow box indicates the inter-quartile range with the central red 
line presenting the median value and the blue line represents the mean quality. 
The upper and lower whiskers denotes the 10% and 90% points. If the mean 
quality score of the last nucleotide was lower than 28, it would be trimmed before 






Figure 29 An example of nucleotide composition from sequenced reads. 
The nucleotide composition of each base position were calculated and visualized 
by software FastQC. A clear bias were noted at the first 14 nucleotides at the 5ʹ 
end of sequence reads: the composition of A, T, C and G were greater or less 
than 25%. This phenomena was caused by the effects of random hexamer 







In addition, to gathering a general idea about coverage saturation, we 
investigated the minimum sequencing coverage required for the detection of 
genes required for both the parasite and human (Figure 30).  We combined 
mapped reads that came from biological replicates at an increasing order for 
each developmental stage to simulate the increase of sequencing depth. The 
number of genes detected were defined as the number of genes with at least one 
read mapped into the CDS region. For example, we examined the number of 
non-zero genes detected in epimastigotes with only HPGL0251, or combined 
samples of HPGL0251 and HPGL0252, or HPGL0251, HPGL0252 and 
HPGL0253. For human samples from the same time point, we observed a 
positive correlation between the number of non-zero genes detected and the 
number of sequenced reads included (Figure 30A). However, the comparison 
between the number of non-zero genes and sequencing coverage across 
samples from different time points did not reveal the same correlation, indicating 
different number of genes were expressed at various stages: with similar 
sequencing coverage, the number of non-zero gene detected was different 
across stages. On the contrary, for T. cruzi samples at the same developmental 
stage, we only noticed increased number of detected genes with deeper 
coverage in stages with relatively low sequencing depth (Figure 30B). In 
trypomastigote and epimastigote samples, where deeper coverage was 
retrieved, the number of detected genes reached saturation with even only one 
replicate included. This discovery was consistent with the global expression 






Figure 30 Number of non-zero genes detected in samples with various 
sequencing depth.  
We plotted the number of genes with at least one read mapped to the CDS (y 
axis) against the number of sequenced reads from each of the developmental 
stages (x axis) included in this study for (A) human and (B) T. cruzi. We 
combined reads from different number of biological replicates of the same stage 





across different developmental stages, in contrast with human, in which a large 
portion of the genes were regulated at the transcriptional level and were not 
expressed, so only in T. cruzi, the increase of sequencing depth can result in the 
plateau of gene detection. 
 
Proportion of reads that can be aligned to T. cruzi or human genomes 
We also examined the number of reads from the pool that mapped to the T. cruzi 
or human reference genomes (Figure 31; Table 8). Each RNA-Seq library 
generated from infected cells consisted of a pool of mixed reads from T. cruzi 
and human fibroblasts. To parse these out, the pre-processed RNA-Seq reads 
were mapped against corresponding reference genomes using the Tophat 
aligner program (Trapnell, Pachter et al. 2009). The genome of the T. cruzi CL 
Brener Esmeraldo haplotype (DTU II) (Berriman, Ghedin et al. 2005) was used 
as the reference to map T. cruzi Y strain sequences (also DTU II) (de Freitas, 
Augusto-Pinto et al. 2006). The human hg19 genome sequences provided a 
reference to map human host cell sequences. The fraction of reads mapping to 
the parasite or human genome references were used to estimate the proportion 
of RNA molecules from each source. In samples from infected cells, where ~30% 
of host cells contained intracellular parasites, a relatively small fraction (2% at 4-
12 hpi) of the mapped read pool aligned to the T. cruzi reference genome at pre-
replication time points (Figure 26). This fraction increased to 28% by 72 hpi, 
reflective of parasite doublings that occur between 24-72 hpi. Nevertheless, the 






Figure 31 Number of mapped reads for T. cruzi and human samples. 
The number of reads that were mapped to (A) T. cruzi and (B) human reference 
genome were computed and displayed for each sample. The x axis indicated the 









Figure 32 Heatmap of Pearson correlation between samples. 
Gene counts were normalized for sequencing library size. All pairwise Pearson 
correlations were calculated and plotted as a heatmap to view the relatedness of 






number of parasite reads do not align to the reference genome when constrained 
by the allowance of no more than two mismatches. This is evident in extracellular 
T. cruzi trypomastigote and epimastigote samples where up to 38% and 44% 
(respectively) of the reads could not be aligned to the reference genome using 
our stringent parameters. Allowing for more mismatches (5) increased the reads 
mapping to the T. cruzi genome to between ~60-70%. The remaining 
unmappable reads likely result from highly polymorphic multicopy gene family 
members, which are usually fast evolving and more divergent in T. cruzi 
(Cerqueira, Bartholomeu et al. 2008). Thus, for the differential gene expression 
analyses reads were mapped with two or fewer mismatches. The relative 
abundance of each CDS was estimated by counting the number of reads 
mapped within the CDS boundaries with the HT-Seq software [http://www-
huber.embl.de/users/anders/HTSeq/]. For T. cruzi samples, mean-variance bias 
of read counts were corrected by package Voom, whereas for human samples, 
the ratio of infected/control counts were used and no mean-variance bias were 
detected (Figure 33). 
 
Global expression profiles  
Our initial analyses examined global expression profiles for consistency between 
similar samples and evaluated experimental variation and reproducibility within 
our datasets. To examine the global gene expression levels of T. cruzi and its 
human host cell, the log2-transformed and size-factor-normalized gene counts 





Figure 33 Mean-variance trend of T. cruzi and human samples. 
We applied Voom package on the R platform to estimate and the mean-variance 
relationship of the log-counts for both T. cruzi (A) and human (B) samples. To 
remove the time progression effects from uninfected human samples, we used 
the ratio of infected/control at each time point in the investigation of differential 
expression genes (See method for details). The mean-variance relationship of 





is graphically depicted as box plots (Figure 34 and Table S14). Mapped read 
counts from parasite extracellular and intracellular stage samples as well as 
human cells displayed consistent degrees of dispersion as indicated by the 
nearly identical quartile distributions in similar samples. A particularly interesting 
observation stems from the examination of the median expression values which 
displayed a compact distribution for parasite genes (with an interquartile range of 
8.8 to 10.8 in epimastigote samples, for example, in Figure 34, T. cruzi) and a 
much broader dynamic range for human genes (interquartile range of 0 to 10) 
(Figure 34, human), highlighting marked differences in transcriptional regulation 
between the two organisms. Gene expression in mammalian cells shows highly 
restricted tissue-specific patterns with complex and tight regulatory mechanisms 
exerted at multiple levels (Cortez, Martins et al. 2012). The resulting gene 
expression profile is a supple one with a wide range of expression and a large 
number of genes not expressed (only 61% of the genes in HFFs are expressed 
here). In contrast, a large majority (98.7%) of trypanosomatid genes are 
expressed during various developmental stages, yet with a much narrower range 
of steady-state transcript level variation. Both features are the result of a general 
lack of control at the transcriptional level with most of the fine-tuning of 
monocistronic mRNA levels occurring mostly at the post-transcriptional level 
through pre-mRNA processing and RNA degradation (Martinez-Calvillo, Vizuet-








Figure 34 Distribution of global gene expression levels in T. cruzi and 
human samples. 
For samples from (A) T. cruzi intracellular and (B) extracellular stages, and (C) 
human , counts were normalized for sequencing library size and a boxplot was 
generated to compare the distribution of per-gene counts (log2 counts per million 
with an offset of 1). The ends of the whiskers represent the lowest datum still 
within 1.5 interquartile range (IQR) of the lower quartile, and the highest datum 
still within 1.5 IQR of the upper quartile. Gene features with extremely high or low 






Assessment of the data with various statistical analysis  
We used Pearson correlation and median pairwise correlation analyses to 
evaluate the reproducibility and experimental variation within our samples. For 
parasite samples, the Pearson correlation matrix revealed high correlation levels 
among biological replicates for each of the developmental stages (Figures 32A, 
39) but also highlighted similarities between the intracellular stages (4 hpi to 72 
hpi) and a contrast with the extracellular stages (trypomastigotes and 
epimastigotes). The correlation matrix for the human transcriptome samples also 
displayed expected correlation levels between biological replicates with the 
exception of one sample (“4hr2”, HPGL0111) which was removed from 
downstream analysis (Figures 32B, 40). The same sample was identified as an 
outlier when we carried out a more systematic median pairwise correlation 
analysis (Figure 35). 
 
In order to investigate general trends in the data and identify and quantify batch 
effects, we carried out principal component analysis (PCA) as well as hierarchical 
clustering visualization of all samples. A high degree of similarity between 
biological replicates is evident in the PCA plots for both T. cruzi and human 
samples (Figure 36). The spreading of points along the first principal component 
reflects the time progression of intracellular amastigote infection. Samples from 
the same time points of infection clustered together for both T. cruzi and human 
samples, although the correlation between infected human samples was less 






Figure 35 Standardized median Pearson correlation between T. cruzi and 
human samples. 
Gene counts were normalized for sequencing library size. The standardized 
median Pearson correlation between each sample and all other samples was 
plotted to view the relatedness of samples and identify outliers for (A) intracellular 
T. cruzi, extracellular T. cruzi (B) and (C) human. Letters [A-E] in the sample 







Figure 36 Principal component analysis of global transcriptome profiles in 
T. cruzi and human host cells at various stages of the infection. 
To evaluate our biological replicates and the relationships between samples 
across time points and to visualize sample-sample distances for genes in (A) T. 
cruzi (extracellular and intracellular forms) and (B) human cells (infected and 
uninfected controls), we conducted a comprehensive principal component 
analysis (PCA) on all collected samples. Very weakly expressed genes were 






drift in the transcriptome of these cells as they grow in tissue culture. Individual 
samples from trypomastigotes and epimastigotes were tightly clustered (Figure 
36). Unsupervised hierarchical clustering of T. cruzi samples identified four 
distinct groups: trypomastigotes, epimastigotes and intracellular amastigotes at 
early (4, 6, and 12 hpi) and late developmental stages (24, 48, and 72 hpi), with 
the exception of a few samples (Figure 37). Hierarchical clustering of human 
samples presented the difference between early and late developmental stages 
of infected samples (Figure 38). The same pattern was observed in uninfected 
human samples indicating a change in the HFF transcriptome over time.  In 
conclusion, our analyses confirm reproducibility between biological replicates, 
enable us to detect temporal progression of samples, and reveal the variation in 
individual transcriptomes. 
 
RNA-Seq, like many other technologies applied in biology, require a complicated 
set of reagents, hardware and highly trained personnel to yield accurate and 
replicable results.  Batch effects were defined as sub-groups of measurements 
that have qualitatively inconsistent behavior across conditions and are irrelevant 
to the biological factors investigated in a study (Leek, Scharpf et al. 2010). In our 
study, samples were prepared by the same laboratory but the infection 
experiments were carried out on five different dates spanning a year period. So 
here we considered experiment date as a distinctive batch source. In this study, 
we carefully examined batch effects in samples by using both PCA and 





Figure 37 Hierarchical clustering of T. cruzi samples. 
Hierarchical clustering analysis based on Euclidean distance was performed 
using all T. cruzi genes after filtering for weakly expressed genes, quantile 
normalization, and inclusion of the batch variable in the statistical model used by 
limma. Colors along the top of the heatmap indicate the developmental stage 







Figure 38 Hierarchical clustering of human samples. 
Hierarchical clustering analysis based on Euclidean distance was performed 
using all human genes after filtering for weakly expressed genes, quantile 
normalization, and inclusion of the batch variable in the statistical model used by 
limma. Colors along the top of the heatmap indicate the developmental stage 








Figure 39 Pairwise Pearson correlation between T. cruzi samples. 
Gene counts were normalized for sequencing library size. The Pearson 
correlation between each sample and all other samples was calculated and 







Figure 40 Pairwise Pearson correlation between human samples. 
Gene counts were normalized for sequencing library size. The Pearson 
correlation between each sample and all other samples was calculated and 






strong batch effects, but a relatively mild one: samples were clustered by 
developmental stages rather than batches; principal components were 
associated with biological conditions, rather than batch effects. However, in our 
samples from certain time points, such as trypomastigote or epimastigote, batch 
effects were highly cofounded with biological variables of interest (developmental 
stages and/or infection). This correlation makes it difficult to determine whether 
observed differences across biological groups are due to biology or artifacts. In 
addition, because of this unbalanced batch design of our samples, particularly 
the extracellular T. cruzi samples, we did not apply Combat package to remove 
batch effects to prevent the overcorrection or bias introduced by the package. 
Instead, we incorporated batch factor as a variable in the linear model that were 
used in statistical analyses. Differentially expressed genes (DEGs) in T. cruzi 
across developmental stages or in mock- or T. cruzi-infected human cells at 
different time points of infection, were identified using the Limma software 
package with t-statistics (Methods). Type I error introduced by multiple testing 
was corrected with q-value (Storey 2002). Differentially expressed genes were 
defined as genes with q-value < 0.05. In addition, to obtain gene lists with bigger 
biological changes, we imposed an arbitrary fold-change cut-off (2-fold) and 
outputted the results. Genes that were identified as differential expressed were 







Unique signatures of gene expression in T. cruzi developmental stages.   
Pairwise comparisons of differential gene expression were made between T. cruzi 
developmental and intracellular infection stages and significantly enriched GO 
functional categories were assigned.  General features of intracellular T. cruzi 
developmental stages emerging in these analyses include a boost in cellular 
metabolic processes, DNA replication and protein translation as parasites transition 
from non-dividing, extracellular trypomastigotes to replicative amastigotes in the 
mammalian host cell (Table S17). Energy generation via citric acid cycle (TCA) cycle 
and proton-coupled ATP synthesis are enriched functions in replicating intracellular 
amastigotes, as are carbohydrate and lipid metabolism including fatty acid, 
isoprenoid and ergosterol synthesis (Table S17). Glycolysis is also found to be an 
enriched GO function in replicating amastigotes, contrary to the belief that glucose 
utilization, while elevated in trypomastigotes, is dampened in amastigotes in favor of 
amino acid and fatty acid catabolism. 
 
During its digenetic life cycle, T. cruzi switches between different developmental 
forms that are well-adapted to life in different hosts and niches within hosts.  As a 
reflection of their divergent lifestyles, we note that the greatest differences in 
steady state transcriptomes are observed between distinct life cycle stages of the 
parasite (Figure 42). With the constraint of minimum fold change of two, between 
~2800 and 3600 DEGs are observed when the transcriptome of the invasive 
extracellular trypomastigote stage is compared with any of the intracellular 





Figure 41 Differentially expressed (DE) genes from human at various 
stages of the infection. 
Edges indicate the pairs of time points for each DE profile. The size of each box 
represents the number of DE genes, with the red and green portions denoting 
up- and down-regulated genes, respectively. A volcano plot from the comparison 







Figure 42 Differentially expressed (DE) genes from T. cruzi at various 
stages of the infection. 
Edges indicate the pairs of time points for each DE profile. The size of each box 
represents the number of DE genes, with the red and green portions denoting 
up- and down-regulated genes, respectively. A volcano plot from the comparison 







transition from trypomastigotes to intracellular amastigotes is initiated by 4 hpi, 
additional changes in parasite gene expression are comparatively modest with 
~400 additional DEGs by 72 hpi (Figure 42, 43; Table S15).  Moreover, once 
replication competent amastigotes are formed by 24 hpi, few additional changes 
in the steady state transcriptome are noted (9 genes) suggesting that large shifts 
in the steady state transcriptome of T. cruzi occur only when the parasite 
undergoes a developmental change.  Without the constraint of fold change, ~ 
7000 and ~9000 genes were detected as differential expressed between 
amastigote and trypomastigote or epimastigote, marking the striking changes of 
transcriptome between intracellular and extracellular stages (Table S15). 
 
Transcripts that were highly over-represented in a single life cycle stage of T. 
cruzi, and poorly represented in others, were considered to be stage-specific 
(Table S20). For example, only genes that were significantly upregulated in one 
specific stage in comparison with the other two were included in this analysis. 
The set of trypomastigote-’enriched’ genes reveals that in addition to hundreds of 
polymorphic surface antigens (comprised of trans-sialidases, mucins, MASPs 
and gp63 surface protease), several glycosyltransferases, protein kinases and 
other signaling proteins such as receptor-type adenylate cyclases were enriched 
in this life cycle stage (Table S20). Epimastigotes had an abundance of ‘stage-
specific’ transcripts encoding metabolic functions (Table S20). The number of 
unique transcripts associated with intracellular amastigotes, was relatively low 





Figure 43 Heatmap of the top 200 T. cruzi genes significantly regulated pre- 
and post- replication at the intracellular stages.  
Yellow bars represent downregulation and blue bars represent upregulation. The 
top 200 significantly regulated with the biggest fold change between 12hpi and 








Figure 44 Heatmap of the top 200 human genes significantly regulated pre- 
and post- intracellular parasite replication. 
Yellow bars represent downregulation and blue bars represent upregulation. The 
top 200 significantly regulated with the biggest fold change between 12hpi and 





the extracellular stages. These included genes coding for surface proteins such 
as amastins - which are one of the few amastigote-specific gene families to be 
characterized (Teixeira, Kirchhoff et al. 1995; Cruz, Souza-Melo et al. 
2012).  Analysis of the hypothetical protein coding genes revealed three highly 
related genes with unique structural features (Tc00.1047053438923.10; 
Tc00.1047053506495.40; Tc00.1047053506495.50) that have not been 
previously described. As the translated proteins are predicted to have signal 
peptides and a variable number of nearly identical repeating peptide sequences. 
Two of them also have predicted GPI anchor attachment motifs (Pierleoni, 
Martelli et al. 2008), these proteins are predicted to be trafficked to the surface of 
the intracellular amastigote where they are in a position to intersect host 
function.  As hypothetical protein coding genes comprise ~60% of the parasite 
genome, parasite stage-specific expression analysis is a powerful tool for 
discovery of novel genes that are expressed in intracellular amastigotes in the 
context of mammalian cell infection. 
 
Early amastigote differentiation in mammalian host cells.   
The time points of intracellular T. cruzi infection analyzed in this study span the 
critical stages of development including trypomastigote-to-amastigote 
differentiation (0, 4, 6, 12 hpi) and intracellular amastigote replication (24, 48, 72 
hpi) (Figure 26).  As illustrated in Figure 42, a dramatic shift in the steady state 
T. cruzi transcriptome coincides with the early establishment of mammalian cell 




receive developmental cues to trigger the transformation to replicative 
amastigotes. Most notable is the rapid downregulation of a large number of 
transcripts encoding the GPI-anchored surface proteins: trans-sialidases, mucins 
and MASPs within the first 4 hours of infection (Table S19) and a concomitant 
increase in the expression of  amastigote-specific genes, such as members of 
the amastin gene family (Teixeira, Kirchhoff et al. 1995; Cruz, Souza-Melo et al. 
2012). Other anticipated findings include the downregulation of parasite genes 
encoding flagellar and paraflagellar rod proteins as motile trypomastigotes 
transition to non-motile amastigotes.    
 
Evidence of altered signal transduction capacities is reflected in the DEG data. 
Trypomastigotes exhibit higher expression of components of cAMP-dependent 
signaling processes such as receptor-type adenylate cyclase, cAMP-specific 
phosphodiesterases, cAMP-dependent protein kinase (PKA) catalytic and 
regulatory subunits than amastigotes. However, the induction of a different PKA 
regulatory subunit gene and a phosphodiesterase in amastigotes at 4 hpi 
suggests stage-specific regulation of a pathway that is recognized as a regulator 
of T. cruzi growth and differentiation (Gonzales-Perdomo, Romero et al. 1988; 
Bao, Weiss et al. 2009). Parasite signaling proteins upregulated in intracellular 
amastigotes include an activated protein kinase C receptor, several putative 
protein kinases, serine/threonine phosphatases as well as a putative protein 
tyrosine phosphatase (Table S19, S21).  Among the most highly expressed, 




Prescott et al. 2003; Hong, Nagamune et al. 2006) and members of a secreted 
lipase family known to be differentially expressed in the amastigote stage 
(Belaunzaran, Wilkowsky et al. 2013). These findings suggest the need for new 
parasite GPI anchor synthesis and present the possibility that parasite lipases 
might participate in vacuole remodeling and egress in addition to manipulation of 
host signaling and cellular processes (Martins Vde, Galizzi et al. 2010). In 
addition to the early induction of signaling components, strong expression of 
several parasite metabolic genes, including urocanate hydratase and 
imidazolonepropionase involved in histidine metabolism, was observed at 4 hpi. 
A number of amino acid permeases are also rapidly upregulated in intracellular 
parasites suggesting an increased reliance on amino acids for energy and/or 
protein synthesis. The significant upregulation of multiple genes encoding rRNA 
subunit proteins, elongation factors, RNA polymerases are consistent with the 
predicted need for increased protein synthesis. Despite the fact that these 
intracellular amastigotes will not undergo their first round of replication for 
another ~20 hours, preparation for the eventuality of cell doubling is already 
apparent at 4 hpi.  The upregulation of nucleoside transporter as well as 
pyrimidine synthesis and purine salvage enzymes are also consistent with 
increased RNA synthesis at this stage and for DNA synthesis at later time 
points.  As intracellular amastigotes advance through their developmental 
program from 4 - 24 hpi, an increasing number of T. cruzi DEGs is observed 





Host cell response after invasion of T. cruzi    
Along with the generation of the first comprehensive T. cruzi transcriptome 
dataset, our RNA-Seq analysis enabled us to simultaneously capture changes in 
the steady state transcriptome of infected human host cells. To identify host cell 
genes that were differentially expressed upon infection at different time points, 
gene expression values obtained from matched mock-infected fibroblasts were 
subtracted from values obtained from infected cells. In the early hours of infection 
(4-12 hpi), 500-600 genes were identified as significantly altered in T. cruzi-
infected fibroblasts as compared to uninfected controls (Table S15).  Consistent 
with previous microarray studies, a type I interferon (IFN) signature (Vaena de 
Avalos, Blader et al. 2002; Chessler, Unnikrishnan et al. 2009; Costales, Daily et 
al. 2009) is observed in our human fibroblast transcriptome.  This signature is 
detectable as early as 4 hpi, where IFN-inducible genes are among the most 
highly expressed genes in infected cells. By 24 hpi, 1458 human genes were 
differentially expressed reflecting both the response to cytosolic amastigotes as 
well as secondary and tertiary responses to soluble factors including type I 
IFNs.  A similar number of fibroblast genes (1176) were modulated at 72 hpi, 
whereas only 339 DEGs were detected at 48 hpi. Variation between independent 
samples at the 48 hpi time point, as shown in the PCA and hierarchical clustering 
analysis, is the likely cause of this anomalously low value. All DEGs for 
comparisons between each pair of time points are reported (Figures 41, 44; 





K-mean cluster and Gene Ontology enrichment analysis for clusters 
To investigate the function representation of genes sharing similar expression 
patterns, K-mean clustering was exploited to group both T. cruzi and human 
genes by the developmental dynamics of their expression patterns (Figures 45, 
46) where enriched functions in each cluster were revealed with GOSeq analysis. 
We defined k equals to 20. For human host cells, most of the GO categories 
showed enrichment for particular clusters of gene expression (Table S24). For 
example, genes that encode enzymes for DNA synthesis, cell cycle regulation 
and chromatin structure, cytoskeleton assembly and organization, protein 
metabolism, potential signaling proteins (phosphatidylinositol or inositol lipid-
mediated signaling) were greatly enriched in clusters 10 and 14, suggesting 
human cells were down-regulating cell proliferation shortly after the replication of 
intracellular parasites started. Genes that show peak expression at 24 hpi or 72 
hpi (clusters 6 and 15) included those that were involved in biological processes 
of production and response to different cytokines, antigen processing and 
presentation, regulation of apoptosis, various pathways involved in immune 
reaction (MDA-5, interferon-gamma-mediated, RIG-I or cytoplasmic pattern 
recognition receptor signaling pathways), reflecting the stressful and defensive 
state of host cells and suggesting that the immune response activates soon after 
the parasite infection and intensifies through different stages. Finally, in cluster 7 
and 20, gene expression is nearly exclusively committed to metabolism and 
biosynthesis with predominant expression of genes that encode enzymes for 





Figure 45 K-means clustering of T. cruzi transcriptome based on the 
dynamic progression of gene profiles across different developmental 
stages. 
The x-axis shows the time points included in the analysis: intracellular 
amastigotes 4hpi-72hpi, trypomastigotes, and epimastigote. The y-axis 






Figure 46 K-means clustering of human transcriptome based on the 
dynamic progression of gene profiles across different developmental 
stages. 
The x-axis shows the time points included in the analysis: 4hpi-72hpi. The y-axis 





alcohol, organic hydroxyl compound and lipid biosynthesis. Genes that encode 
enzymes and transporters for organic cyclic compound metabolism, aromatic 
compound metabolism, ubiquitin-dependent protein catabolic process and 
muscle cell differentiation were also greatly enriched in this segment. Together, 
these data revealed that the major biochemical shifts along the infection process 
are produced in part by highly dynamic, coordinated and localized transitions in 
mRNA abundance. 
 
For T. cruzi, most of the GO categories also showed enrichment for particular 
clusters of gene expression (Figure 45; Table S23). For example, in cluster 5 
very abundant transcripts were detected for genes annotated as encoding DNA 
recombination, DNA replication, DNA repair, and telomere maintenance. Genes 
predicted to encode proteins involved in ATP synthesis coupled proton transport, 
phosphorylation and cell redox homeostasis were also disproportionally 
represented in the same cluster. This group of genes increased their expression 
levels throughout the intracellular stages with the highest level at epimastigote 
stage and the lowest at trypomastigote stage. Genes contributing to Cluster 6 
included those annotated as regulation of translational initiation, elongation or 
termination, ribosome biogenesis, protein folding, tRNA aminoacylation, 
translational frameshifting, suggesting active translational regulation at 
epimastigote stage. The greatest enrichment in cluster 20 was observed for 




transport, cell adhesion, proteolysis followed by translational elongation and 
pathogenesis, with major changes occurred at epimastigote stage. 
 
Gene set enrichment analysis 
The Gene set enrichment analysis tool (GSEA) developed by the Broad Institute 
was applied to investigate functional associations of gene expression changes 
between different set of comparisons (Subramanian, Tamayo et al. 2005), 
supplementary materials). DEGs that were up- or down- regulated were analyzed 
by functional clustering. Kyoto Encyclopedia of Genes and Genomes (KEGG) 
was selected as the priori defined annotation category for enrichment analysis of 
human genes and Gene Ontology (GO) terms was selected for T. cruzi 
(Ashburner, Ball et al. 2000; Kanehisa and Goto 2000). Once the tool has ranked 
the DEGS according to the magnitude of their fold change, it identifies enriched 
KEGG/GO categories and assigns a statistical significance based on the number 
and the ranking of the constituent genes. We performed this analysis on all 
significantly regulated gene lists reported in the previous step.  
 
For the human samples, functions associated to cytokine receptor interaction, 
chemokine signaling pathway, Nod-like receptor signaling pathway, Rig-like 
receptor signaling pathway, and Toll-like receptor signaling pathway were 
enriched in most of the developmental stages post invasion of T. cruzi. The 
enrichment of other functions related to human immune response were also 




receptor signaling pathway and epithelial cell signaling in helicobacter pylori 
infection at 24 hpi, and cytosolic DNA-sensing pathway at 72 hpi. The Jak-STAT 
signaling pathway were also up-regulated at 12 hpi. Interestingly, the enrichment 
of KEGG categories related to the rise of cytosolic Ca2+ concentration was also 
detected at late stages of infection.  More than 20 genes, encoding adenylate 
cyclase, angiotensin II receptor, calcitonin receptor, potassium large 
conductance calcium-activated channel, guanylate cyclase, protein kinase 
phospholipase A2 were significantly upregulated at 48 and 72 hpi. Typical clinical 
manifestations of chronic phase of Chagas disease are grouped into three major 
forms: cardiac, digestive, and cardiodigestive, all of which can be linked to the 
attacks against the smooth muscle cells (SMCs), combined with the inflammation 
caused by long-term infection. However, the reason for the proneness of SMCs 
to the attack from T. cruzi and the mechanisms behind these symptoms were still 
unclear. The principal mechanisms involved in the regulation of smooth muscle 
cells rely on the modulation of cytosolic Ca2+ concentration. Specifically, the 
increase of calcium concentration triggers the Ca2+-CaM-MLCK pathway and 
stimulates MLC20 phosphorylation, leading to myosin-actin interactions and, 
hence, the development of contractile force. During receptor stimulation, the 
contractile force is greatly boosted by the inhibition of myosin phosphatase 
(Abdel-Latif 2001). Our data provided an interesting gene list that may contribute 
to the understanding of the disease and may help in identification of targets for 





By contrast, genes from T. cruzi known to be involved in sialidase activity, 
pathogenesis, and cell outer membrane were enriched in trypomastigotes. An 
overrepresentation of gene functions related to nucleosome assembly, DNA 
replication, DNA packaging, DNA recombination, translation, ribosome, 
kinetoplast, protein folding, ATP synthesis coupled proton transport and cell cycle 
at epimastigotes and amastigotes 24-72 hpi indicated the ongoing process of 
replication inside the insect host. Other enriched functions detected at the same 
time period, such as cell redox homeostasis, oxidation-reduction process, iron-
sulfur cluster assembly, implied the actively regulated reaction in mitochondrial 
electron transport. We also noticed the overlap of many enriched functions 
between amastigotes 24-72 hpi and epimastigotes, between the early time points 
of 4 hpi and 6 hpi.  
 
Motif analysis for coexpressed T. cruzi genes 
In organisms like Trypanosoma cruzi and its kinetoplastid relatives, genes are 
transcribed as long polycistronic units that are trans-spliced, cleaved and 
processed post-transcriptionally.  Thus, genome-wide differences in transcript 
abundance, as highlighted in the analyses of our RNA-Seq data, is primarily a 
consequence of post-transcriptional processes that exploit trans-acting regulatory 
factors.  RNA-binding proteins are predicted to function in this capacity by 
recognizing cis-acting post-transcriptional regulatory elements located in the 
UTRs of mRNAs, as in other cellular systems.  As such, the discovery of 




genomic analysis.  We applied XXmotif software (Luehr, Hartmann et al. 2012) to 
identify enriched sequence motifs in both the 3ʹ and 5ʹ UTRs of T. cruzi 
transcripts that have carefully defined in Chapter 2 for each of the coexpression 
gene clusters (Figure 47). XXmotif is a tool that can directly optimize the 
statistical significance of position weight matrix (PWMs), and score conservation 
and positional clustering of motifs. The motif size was restricted to 6 nucleotides 
in our analysis, since one of the common motifs identified in trypanosomes is the 
Adenylate/Uridylate (AU)-rich elements (ARE), of which the core sequence is 
usually consisted of less than 6 nucleotides (Chen and Shyu 1995; Peng, Chen 
et al. 1996). In general, more motifs were identified in 5ʹ UTRs as compared to 3ʹ 
UTRs.  A total of 1566 motifs were identified in the 5ʹ UTRs of the 20 clusters 
versus 544 in the 3ʹ UTRs. 
 
Several of the motifs we identified (Tables S25, S26) match known cis-acting 
elements involved in post-transcriptional regulation in trypanosomes. For 
example, the canonical cycling sequence (CS) CAUAGAAG, located in the 5’-
UTR, is known to be recognized by Cycling Sequence Binding Protein (CSBP) II 
complex that is responsible for the regulation of a cohort of transcripts (Pasion, 
Hines et al. 1996; Mahmood, Mittra et al. 2001). Analysis of T. cruzi gene 
expression clusters revealed the enrichment an UAGAAG motif in the 5ʹ UTRs of 
cluster 14, a group of genes for which expression gradually increases over the 
course of the intracellular infection cycle and were most highly expressed in 






Figure 47 Overrepresented motifs detected in the 3' UTR of cluster 1 in T. 
cruzi.  
Package XXmotif were applied to identify enrichment of motifs in the UTRs of 
gene clusters in T. cruzi. The top 12 of overrepresented motifs were presented 
here. The black bars indicate the position weighted matrix of motifs; the blue and 




remarkably increased expression of cell cycle sequence binding phosphoprotein 
(Tc00.1047053508541.190 and Tc00.1047053506777.50) at both epimastigote 
and trypomastigote stages in the differential expression analysis implying the 
regulation by the two trans-acting factors on this group of genes. 
Overrepresentation of AU-rich elements were also detected in our analysis. For 
example, the well conserved AUGUAU motif (Gerber, Herschlag et al. 2004; 
Archer, Inchaustegui et al. 2011), which contains a putative PUF-family RNA-
binding domain core UGUA, was detected in the UTRs of multiple gene clusters 
(Cluster 2, 4, 7, 12, 14, 15, 16, and 19).  As RNA-binding proteins are known to 
form complexes with other regulatory proteins, the presence of a putative PUF 
recognition motif in multiple coexpressed gene clusters may indicate 
combinatorial control of regulation. Recently, Frasch and colleagues investigated 
the enrichment of motifs in 53 gene clusters that share similar KEGG pathways 
(De Gaudenzi, Carmona et al. 2013). They were able to capture several 
sequence patterns in the 3ʹ UTR for each of the metabolically related gene 
clusters. It should be noted that in their analysis, without the accurate definition of 
3ʹ UTR boundaries, they searched 350 nt downstream of the end of the CDS, 
whereas in our motif analysis, we were able to examine the UTRs that were 
precisely identified in previous chapter. A comparison of the motifs detected in 
our analysis to those reported by Frasch’s team, revealed significant overlap of 
motifs between the coexpressed gene clusters and genes sharing similar KEGG 
pathways (Tables S25, S26). In particular, we were able to match the sequence 




in previous study indicating the RBP may function at either location, a 
phenomena that were previously noted in T. brucei as well (Archer, Inchaustegui 
et al. 2011). The conservation of sequence motifs in these regulated transcripts 
in trypanosomes further reinforce their potential functional consequences. 
 
Relating transcriptome and function.   
To determine if any of the host genes found to be differentially expressed 
following T. cruzi infection, have predicted functional roles in the parasite 
infection process, DEG data from our current study was compared with genome-
scale functional data from the recent RNA-interference screen in HeLa cells to 
find the intersection (Caradonna, Engel et al. 2013). Of ~700 genes, that when 
silenced with siRNA pools exhibited a significant decrease (~380 genes) or 
increase (~320 genes) in intracellular T. cruzi infection, we find overlap with 50 
differentially expressed human fibroblast genes in at least one of the infection 
time points (4-72 hpi; Table S27). Gating on human genes for which a > 2-fold 
change in expression occurred at any of the infection time points, we noted a 
strong correlation between the most highly upregulated genes and decreased 
parasite infection when these genes were silenced in the RNAi screen. This 
suggests that during the course of intracellular infection, T. cruzi induces (directly 
or indirectly) the expression of host genes that are beneficial to the establishment 
and maintenance of parasite infection. In support of this prediction, we highlight 
an example for which functional validation exists: GTP-cyclohydrolase 1 (GCH1) 




synthesis of tetrahydrobiopterin (BH4).  As pterin auxotrophs, T. cruzi amastigotes 
must scavenge these essential nutrients from the host. Our previous work 
showed that siRNA-mediated knockdown of host GCH1 impairs intracellular T. 
cruzi growth in a manner that could be rescued by the addition of exogenous BH2 
(Caradonna, Engel et al. 2013). Our transcriptomic data now reveals potential 
compensatory upregulation of this host pathway to service the increased demand 
for biopterin with the induction of GCH1 transcript levels beginning at 12 hpi 
(Table S27).  Compensation appears to be occurring in the parasite as well, with 
the rapid upregulation of pterin-4-alpha-carbinolamine dehydratase in T. cruzi at 
4 hpi.  The involvement of this enzyme in BH4 recycling is consistent with a need 












2.5 Conclusion and discussion 
Characterization of parasite and host transcriptomes during the course of 
intracellular infection provides fundamental insight into the dynamics of the host-
pathogen interaction. Several studies have exploited microarray expression 
profiling to investigate the host response to T. cruzi infection in a variety of cells 
in vitro and in vivo (Shigihara, Hashimoto et al. 2008; Minning, Weatherly et al. 
2009; Zhang, Kim et al. 2010; Manque, Probst et al. 2011; Tanowitz, 
Mukhopadhyay et al. 2011; Grynberg, Passos-Silva et al. 2012; Caradonna, 
Engel et al. 2013). The work presented here is the first simultaneous deep 
transcriptomic surveys of both T. cruzi and its human host cells across an 
intracellular infection time course. To enhance the comparison, we have obtained 
transcriptomic data for the invasive trypomastigote form as well as the axenic 
insect vector stage, the epimastigote form.  The earliest infection time point 
analyzed, 4 hpi, reveals a substantial number of changes in steady state 
transcript abundance in both T. cruzi and its host.  The parasite, having entered 
the host cell as highly motile, non-dividing trypomastigotes that express an 
abundance of several polymorphic surface antigens, quickly downregulates these 
surface antigens, along with motility functions as an early step in the transition to 
a non-motile amastigote. The surface antigens: trans-sialidases, mucins and 
MASPs are predominantly expressed in the trypomastigote form (including 
metacyclic trypomastigotes that arise from epimastigotes and not profiled here) 




pathways in mammalian cells (Chuenkova, Furnari et al. 2001; Chuenkova and 
PereiraPerrin 2009).  Consistent with the need for T. cruzi to prepare for 
replication in the host cell cytosol, there is evidence from the transcriptome of 
generalized upregulation of biosynthetic processes, occurring as early as 4 
hpi.  These include RNA, protein, fatty acid, isoprenoid and sterol synthesis.  As 
the amastigote developmental program is pursued, DNA replication functions in 
the parasite are upregulated to prepare the amastigote for the initiation of S-
phase at ~16 hpi and finally cell division at ~22 hpi.  Strikingly, few additional 
changes in parasite gene expression occur between 24 - 72 hpi while the 
parasite is undergoing active replication.  On the host side, parasite infection 
triggered an innate immune response within the first few hours of infection and 
maintained this feature throughout the course of infection.  These findings differ 
markedly from those of early microarray studies, where significant upregulation of 
host genes in HFF was not observed in the first few hours of infection (up to 6 
hpi) while the overall response at 24 hpi had a similar type I IFN signature 
(Vaena de Avalos, Blader et al. 2002). At the chronic phase of Chagas disease, 
patients often develop digestive or/and cardiac clinical manifestation, all of which 
can be linked to the attacks against the smooth muscle cells (SMC), combined 
with the inflammation caused by long-term infection (Lescure, Le Loup et al. 
2010; Rassi, Rassi et al. 2010). However, the reason for the proneness of SMCs 
to the attack from T. cruzi and the mechanisms behind these symptoms were still 
unclear. Interestingly, our data has revealed that genes related to the modulation 




infection, which can further change the myosin-actin interactions and, hence, the 
development of contractile force of SMCs. In contrast to earlier microarray 
studies, deep sequencing methods used here have enabled us to detect early 
changes in host gene expression in response to parasite infection. These results 
provide a clear example of how transcriptomic profiling of intracellular T. cruzi 
amastigotes and human host can provide critical insights into the biochemical 
features of this pathogen and the identification of potential drug targets. 
 
For both host and parasite, genes that shared dynamic expression patterns were 
clustered to reveal enriched functions and pathways. Protein-coding genes in T. 
cruzi do not have pol II promoters like the majority of eukaryotes and the 
regulation of gene expression levels occurs primarily at the post-transcriptional 
level (Teixeira, Kirchhoff et al. 1995; Teixeira and daRocha 2003; Martinez-
Calvillo, Vizuet-de-Rueda et al. 2010). However, neither a genome-wide gene 
structure analysis nor a systematic search of regulatory elements has been done 
for T. cruzi. Through the use of ultra high-throughput sequencing, we completed 
the gene structure model of T. cruzi in Chapter 2. We also identified potential 
regulatory elements located in the UTR regions for each gene cluster in T. cruzi. 
The transcriptional and functional studies reported in this work provided a 
fundamental framework for various network analyses for both species, such as 





Some strains of T. cruzi parasite (for example Y strain and CL-Brener strain) can 
cause life-threatening disease while others can be non-virulent (such as G 
strain). It has been proposed that differences in the pathogenic potential between 
disease isolates might be influenced by small genetic differences in genes from 
the core genome (de Freitas, Augusto-Pinto et al. 2006; Cortez, Martins et al. 
2012). However, differences in the pathogenic potential of strains can be also 
attributed to differences at the transcriptional level that can be identified by 
performing comparative transcriptomic analyses of different parasite strains. We 
propose that the analysis of the transcriptional response of T. cruzi strains 
with/without the infection might represent a new approach to discriminate 
between the virulence potentials of different isolates. 
 
In the field of T. cruzi pathogenesis, this first analysis of gene expression after 
invasion of human hosts significantly increases the knowledge of how these 
parasites survive and manipulate responds to human blood and causes 
sepsis. The findings reported in this study could also be helpful to identify the 
function of gene products annotated as hypothetical proteins, understand the 
regulation of vaccine antigens in blood and ultimately develop diagnostic and 







  Chapter 4: Conclusion remarks and future perspective 
Trypanosoma cruzi is a unicellular eukaryotic parasite with a digenetic life cycle 
alternating between the triatomine insect and a variety of mammalian hosts. It 
can cause Chagas disease, which is ranked as one of the seventeen neglected 
diseases by WHO. An estimated 10 million people suffer from this forgotten 
scourge (Rassi, Rassi et al. 2010).  Most of them are the most vulnerable 
populations with limited resources and public voice. No vaccine is available and 
current treatments are very limited and highly toxic. This disease has significant 
economic impact in Latin America and has been classified by the World Bank as 
one of the main public health problems on South American continent (WHO 
2002). Besides its importance as a human and veterinary pathogen, T. cruzi, 
together with sister species like T. brucei and L. major, has been key to the 
discovery and understanding of general biological principles such as trans-
splicing, RNA editing, antigenic variation, and immune evasion (Borst and Cross 
1982; Sutton and Boothroyd 1986; Simpson, Shaw et al. 1988; McCabe and 
Mullins 1990; Thomas, Martinez et al. 2007). In this study, we applied a high 
throughput RNA sequencing approach to investigate the transcriptome of the 
pathogen and infected human hosts simultaneously. In addition, we included the 
transcriptome of two extracellular stages of T. cruzi in order to capture its 
complete life cycle. In our experiments, a total of 2.7 billion reads from 34 
samples across 6 intracellular stages and 2 extracellular stages were sequenced. 
The sequencing depth and single-nucleotide resolution allowed us to scrutinize 






Unlike other eukaryotes, trypanosome genes coding for proteins with unrelated 
functions are organized into co-directional clusters that undergo polycistronic 
transcription by RNA polymerase II (Pol II) (El-Sayed, Myler et al. 2005; Siegel, 
Tan et al. 2005; Siegel, Gunasekera et al. 2011). Trans-splicing, together with 
polyadenylation, allows polycistronic transcripts to be processed into 
monocistronic units ready for translation (El-Sayed, Myler et al. 2005; Daniels, 
Gull et al. 2010).The lack of identifiable RNA pol II promoters in trypanosomatids 
suggests that these organisms lack precise transcriptional control over the 
majority of their genes (Siegel, Gunasekera et al. 2011). Thus, regulation of gene 
expression occurs mainly at the post-transcriptional level, through pre-mRNA 
processing, RNA degradation, or translational repression (Martinez-Calvillo, 
Vizuet-de-Rueda et al. 2010). To date, very little is known about the way in which 
trypanosomes regulate transcription or translation, but in many other eukaryotes, 
the 5ʹ and 3ʹ UTRs contain sequence elements that are responsible for regulating 
RNA or protein synthesis. So characterizing the RNA processing events in T. 
cruzi is of great significance in the efforts of understanding the biology of the 
pathogen.  
 
Because our study design was mainly aimed at a quantitatively unbiased profiling 
of the transcriptome of the parasite at various developmental stages, we did not 




on deep coverage to collect relatively large numbers of reads from both ends of 
transcripts (6.4 million SL- and 1.1 million polyA-containing reads). This approach 
permitted us to identify as well as quantitate differential RNA processing events.  
Strikingly, our genome-wide study successfully identified trans-splicing and 
polyadenylation sites for more than 80% of the genes. A very high degree of 
heterogeneity of RNA processing sites were noted in T. cruzi. This phenomena 
were also observed in other trypanosomes as well. In addition, our experiment 
captured identical alternative trans-splicing sites for gene LYT1 reported by 
Swindle’s team using PCR amplification of reverse transcribed mRNA in 2002. 
This further confirmed the accuracy and sensitivity of our high throughput 
sequencing approach. Most surprising was that a large number of transcripts 
showed differential abundance of alternative splice variants across different life 
stages. More than 198 differentially spliced transcripts were detected between 
amastigote 72 hpi, epimastigote and trypomastigote supporting the idea that 
alternative splicing may have functional consequences for the regulation of 
parasite survival and development, of which the corresponding regulatory factors 
remain elusive. Alternative splicing patterns have been observed in T. brucei 
during development as well (Nilsson, Gunasekera et al. 2010). Four possible 
functional consequences can be summarized: First, alternative splicing can result 
in potentially untranslatable transcript with incomplete ORFs; second, it can lead 
to different length of transcripts with the inclusion or exclusion of signal peptide or 
other anchoring signals present as a potential mechanism for dual localization of 




variant of the transcripts; fourth, splicing events may allow usage of a novel ORF 
because of the inclusion of alternative start codon. More questions can be asked 
with regards to the different splicing patterns: if the splicing events are regulated; 
if yes, how does the splicing machinery adapt under different developmental 
stages; if the resulting variants are targeted to different cellular compartments or 
possess altered stabilities; if the inclusion of some sequence motifs on the 
variants can lead to different translational efficiency. The identification of potential 
sequence motifs located in the 5ʹ or 3ʹ UTRs, particularly those that will be 
selectively included through different splicing events can be very helpful in 
explaining the function of alternative splicing.  
 
Several studies have been conducted with the oligonucleotide microarray 
technique (microarray) to investigate either the transcriptome of T. cruzi or 
infected human cells (Shigihara, Hashimoto et al. 2008; Minning, Weatherly et al. 
2009; Zhang, Kim et al. 2010; Manque, Probst et al. 2011; Tanowitz, 
Mukhopadhyay et al. 2011; Grynberg, Passos-Silva et al. 2012; Caradonna, 
Engel et al. 2013). The research group of Tarleton have conducted genome-wide 
expression profile analyses, revealing differentially expressed genes at four life-
cycle stages of T. cruzi (Minning, Weatherly et al. 2009). In another study, 
researchers investigated the transcriptome of T. cruzi-infected HeLa cells and 
detected 64 genes with three-fold changes (Shigihara, Hashimoto et al. 2008). 
However, these studies only examined gene expressions in either T. cruzi or 




the transcriptomes across the infection cycle which are essential for the 
understanding of host-pathogen interaction. The expression profiles of both T. 
cruzi and human genes in a spatially and temporally equivalent biological sample 
could help us to understand the molecular mechanisms of both host defense and 
pathogen infection strategies simultaneously. To date, our study is the first one 
analyzing the genome-wide expression profiles of both the human and T. cruzi 
genes simultaneously in the same infected sample with RNA-Seq technology. 
Compared with microarrays, RNA-Seq is known to have a wider dynamic range, 
higher technical reproducibility, and provide a better estimate of absolute 
expression levels (Marioni, Mason et al. 2008; Fu, Fu et al. 2009). 
 
RNA-Seq, like many other technologies applied in biology, requires a 
complicated set of reagents, hardware and highly trained personnel to yield 
accurate and replicable results.  Batch effects were defined as sub-groups of 
measurements that have qualitatively inconsistent behavior across conditions 
and are irrelevant to the biological factors investigated in a study (Leek, Scharpf 
et al. 2010). These kind of technical effects can originate from various laboratory 
conditions, reagent brands and lots, equipment, as well as personnel differences, 
If not properly handled, batch effects can be a common and powerful source of 
variation, making the task of combining data from different batches difficult. 
Several examples have been reported in published studies, which biological 
variables were impacted by batch effects and raised concerns about the validity 




Scharpf et al. 2010). Currently, several statistical solutions have been proposed 
to adjust for batch effect, including surrogate variable analysis (SVA) (Leek and 
Storey 2007) and Combat (Johnson, Li et al. 2007). In our study, samples were 
prepared by the same laboratory but the infection experiments were carried out 
on five different dates spanning a year period. So here we considered 
experiment date as a distinctive batch source. We quantified and visualized 
batch effects using both PCA and hierarchical clustering dendrograms (Figures 
36, 37, 38). We did not observe strong batch effects, but a mild one: samples 
were clustered by developmental stages rather than batches; principal 
components were associated with biological conditions, rather than batch effects. 
However, in our samples from certain time points, such as trypomastigote or 
epimastigote, batch effects were highly cofounded with biological variables of 
interest (developmental stages and/or infection). This correlation makes it difficult 
to determine whether observed differences across biological groups are due to 
biology or artifacts. In addition, because of this unbalanced batch design of our 
samples, particularly the extracellular T. cruzi samples, we did not apply Combat 
to remove batch effects to prevent the overcorrection or bias introduced by the 
package. Instead, we incorporated batch factor as a variable in the linear model 
that were used in statistical analyses. In future studies with high throughput data, 
especially for those dealing with time series, a more balanced experiment design 
may minimize the batch effects or facilitate the correction of potential technical 




needed so that the specific sources of batch effects can be isolated and the 
dependence on surrogates can be reduced. 
 
Complementary research that can be done after this study is network analysis. 
The establishment of transcriptome profiles for both T. cruzi and human will allow 
researchers to study gene coexpression, the process by which genes are 
expressed in coordination to produce proteins. For example, weighted gene 
correlation network analysis (WGCNA) can be used for finding modules of highly 
correlated genes and for summarizing these clusters of genes by identifying their 
eigengene (Langfelder and Horvath 2008). Network analyses have been 
proposed as a solution to systems biology studies, particularly those involving 
transcriptomic datasets(Zhang and Horvath 2005). This approach can model the 
interactions of real biological networks and can intuitively visualize the 
relationships between modules (Aoki, Ogata et al. 2007; Horvath and Dong 
2008). The clustering of co-expressed genes into "modules" mirrors regulatory 
associations found in biological systems and provides information on unknown 
genes through "guilt by association" with well-characterized ones in the same 
cluster (Zhang and Horvath 2005). Motif findings can also be carried out in genes 
that share similar expression patterns (Wernicke and Rasche 2006). In particular, 
the highly connected “hubs” identified in T. cruzi coexpression networks may play 
an essential role either by influencing the expression patterns of other genes or 
alternatively communicating changes that occur elsewhere in the network and 





With the rapid drop of sequencing cost, comparative sequencing has entered a 
new era.  A wide range of evolutionary and pathological questions within the T. 
cruzi lineage can be answered by sequencing analyses of additional T. cruzi 
isolates. In this study, we constructed the transcriptome of T. cruzi Y strain (DTU 
II), which is one of the most virulent strains and often proposes as a lethal 
challenge. In contrast, BALB/c mice injected with CL-14 trypomastigotes, a non-
virulent strain, showed no or limited parasitaemia but high level of resistance 
(Lima, Lenzi et al. 1995).  Comparisons between the transcriptomes of Y strain 
and non-virulent strains like CL-14 or G strain may help identify the key factors 
involved in the pathogenesis of Chagas and generate an interesting gene list that 
may restore the virulence of CL-14. In addition, we can compare the usage of 
different RNA processing sites between strains. The conservation of site usage 
indicates the functional consequences of the RNA processing sites and may help 
identify motifs involved in these choices; whereas, different trans-splicing sites, 
resulting in transcripts with different lengths, may propose as an explanation for 
the virulence of Y strain. 
 
Ribosomal profiling (Ribo-Seq) technology can be a good complement to RNA-
Seq experiments helping us understand both trans-splicing and polyadenylation 
events. Ribo-Seq produces a global picture of the positions of all the active 
ribosomes in a cell, thus allowing us to accurately pinpoint the translational start 




Seq, can help us examine whether alternative trans-splicing events, or the 
presence of certain motifs, can lead to different translational start site, thus 
various protein products. In addition, it can allow us to correctly identify the start 
codon for annotated and novel ORFs.  It will also be of particular interest to 
investigate the association of alternative RNA processing events with 
translational efficiency. If a positive correlation can be established between the 
two, the diverse splicing patterns detected at different developmental stages 
could be an efficient approach by T. cruzi to adjust its protein levels across time. 
Other genomic features, for example the spacing between trans-splicing sites 
and upstream polyadenylation site or the length of UTRs, may also play a role in 
the regulation of alternative translation start site or translational efficiency. Ribo-
Seq may help in the elucidation of the above questions. The combination of 
RNA-sequencing and ribosome profiling technologies can bridge the gap 
between gene express level and protein synthesis (Ingolia 2014). A future 
direction and good complement of this study is to construct the ribosome profiling 
(Ribo-Seq) for T. cruzi across its development stages. Since trypanosomes do 
not follow a rigid regulation at the transcriptional level, it will be of particular 
interests to generate global measurements of translation that are as precise and 
detailed as data derived from RNA-Seq. Ribo-Seq can be used to identify 
translated sequences within the profiled parasite transcriptome, to monitor the 
process of translation and the maturation of nascent polypeptides in vivo, and to 




between transcriptional level and translational level can provide new insights into 
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stage Infected Batch Trimmed  
HPGL0063 
Amastigote                 
4 hpi 
N A   
HPGL0064 Y A Y 
HPGL0111 Y B   
HPGL0112 Y C   
          
HPGL0065 
Amastigote 6hr 
N A   
HPGL0066 Y A Y 
HPGL0113 Y B   
HPGL0114 Y C Y 




N A   
HPGL0068 Y A Y 
HPGL0115 Y B Y 




N A   
HPGL0070 Y A Y 
HPGL0116 Y B Y 
HPGL0117 Y C Y 




N D   
HPGL0071 N A Y 
HPGL0257 N C   
HPGL0056 Y D   
HPGL0060 Y D   
HPGL0072 Y A Y 
HPGL0258 Y C   




N D   
HPGL0255 N E   




HPGL0061 Y D   
HPGL0256 Y E   
          
HPGL0062 
trypomastigote 
N A Y 
HPGL0249 N E   
HPGL0250 N E   
HPGL0251 N E   
          
HPGL0252 
epimastigote 
N E   
HPGL0253 N E   














Number of reads that 
pass Illumina filter 
Total number of 
reads mapped 
% of total reads 
mapped 
HPGL0063 75,455,946 72,024,476 95.45% 
HPGL0064 139,558,460 130,016,017 93.16% 
HPGL0111 123,249,854 81,724,984 66.31% 
HPGL0112 98,909,298 94,669,006 95.71% 
        
HPGL0065 63,327,220 60,735,117 95.91% 
HPGL0066 157,401,226 148,513,778 94.35% 
HPGL0113 112,249,358 106,802,654 95.15% 
HPGL0114 97,411,582 91,909,631 94.35% 
        
HPGL0067 67,337,918 64,902,003 96.38% 
HPGL0068 88,441,820 83,974,766 94.95% 
HPGL0115 93,933,948 89,531,503 95.31% 
        
HPGL0069 66,477,092 64,617,122 97.20% 
HPGL0070 88,843,990 84,786,038 95.43% 




HPGL0117 74,297,462 70,880,898 95.40% 
        
HPGL0055 57,701,782 48,117,142 83.39% 
HPGL0071 69,490,186 68,360,413 98.37% 
HPGL0257 91,887,850 90,007,520 97.95% 
HPGL0056 57,701,782 52,398,585 90.81% 
HPGL0060 57,692,178 52,602,786 91.18% 
HPGL0072 77,919,340 70,119,342 89.99% 
HPGL0258 76,483,856 67,999,152 88.91% 
        
HPGL0057 60,211,156 58,562,661 97.26% 
HPGL0255 77,417,180 76,347,021 98.62% 
HPGL0058 49,143,458 40,315,329 82.04% 
HPGL0061 65,873,648 54,571,365 82.84% 
HPGL0256 90,450,622 87,107,335 96.30% 
        
HPGL0062 105,944,210 65,836,443 62.14% 
HPGL0249 59,465,792 37,831,725 63.62% 
HPGL0250 55,394,756 36,057,541 65.09% 
HPGL0251 54,424,652 35,121,149 64.53% 
        




HPGL0253 59,156,660 34,484,732 58.29% 
HPGL0254 52,314,436 29,335,454 56.08% 
        
Total 2,710,883,714 2,361,563,057 87.11% 






Table 8 Summary of mapping statistics to individual genomes 
Lab sample 
ID 
Reads mapped to 




% of reads mapped 
to T. cruzi 
Esmeraldo 
haplotype 
% of reads 
mapped to 
hg19 
HPGL0063   72,024,476   100.00% 
HPGL0064 2,585,633 127,430,384 1.99% 98.01% 
HPGL0111 2,257,327 79,467,657 2.76% 97.24% 
HPGL0112 2,928,987 91,740,019 3.09% 96.91% 
          
HPGL0065   60,735,117 0.00% 100.00% 
HPGL0066 3,128,883 145,384,895 2.11% 97.89% 
HPGL0113 2,014,693 104,787,961 1.89% 98.11% 
HPGL0114 2,811,907 89,097,724 3.06% 96.94% 
          
HPGL0067   64,902,003 0.00% 100.00% 
HPGL0068 1,769,313 82,205,453 2.11% 97.89% 
HPGL0115 2,136,351 87,395,152 2.39% 97.61% 
          
HPGL0069   64,617,122 0.00% 100.00% 
HPGL0070 4,635,117 80,150,921 5.47% 94.53% 




HPGL0117 4,982,378 65,898,520 7.03% 92.97% 
          
HPGL0055   48,117,142 0.00% 100.00% 
HPGL0071   68,360,413 0.00% 100.00% 
HPGL0257   90,007,520 0.00% 100.00% 
HPGL0056 6,866,656 45,531,929 13.10% 86.90% 
HPGL0060 6,985,398 45,617,388 13.28% 86.72% 
HPGL0072 13,138,673 56,980,669 18.74% 81.26% 
HPGL0258 19,099,189 48,899,963 28.09% 71.91% 
          
HPGL0057   58,562,661 0.00% 100.00% 
HPGL0255   76,347,021 0.00% 100.00% 
HPGL0058 15,056,971 25,258,358 37.35% 62.65% 
HPGL0061 19,546,061 35,025,304 35.82% 64.18% 
HPGL0256 8,327,776 78,779,559 9.56% 90.44% 
          
HPGL0062 65,836,443   100.00%   
HPGL0249 37,831,725   100.00%   
HPGL0250 36,057,541   100.00%   
HPGL0251 35,121,149   100.00%   
          
HPGL0252 37,693,521   100.00%   
HPGL0253 34,484,732   100.00%   




          
Total 398,535,152 1,963,027,905 14.70% 72.41% 




Appendix 4:  Supplementary table index 
All supplementary tables were submitted together with this thesis. 
 
Table S1. Summary of features for RNA processing events. This table 
contains the number of T. cruzi reads, SL-containing reads, poly(T)-containing 
reads, and the number of RNA-processing sites detected. 
 
Table S2. T. cruzi 5ʹ UTR coordinates ORF-containing 5ʹ UTRs excluded. 
This table includes the coordinates of all 5ʹ UTRs detected for annotated CDSs 
and the number of SL-containing reads mapped to corresponding sites at each 
time point. UTRs containing open reading frames were excluded from output.  
 
Table S3. T. cruzi 3ʹ UTR coordinates ORF-containing 3ʹ UTRs excluded. 
This table includes the coordinates of all 3ʹ UTRs detected for annotated CDSs 
and the number of poly(T)-containing reads mapped to corresponding sites at 
each time point. UTRs containing open reading frames were excluded from 
output.  
 
Table S4. Function distribution of genomic features with extreme values. 
This table includes the function frequency of genes with extreme values of 
genomic features for T. cruzi and T. brucei. The data from T. brucei were 





Table S5. Coordinates of 5ʹ UTR for all CDSs existing and novel. This table 
includes the coordinates of all 5ʹ UTRs detected for both annotated and novel 
CDSs and the number of SL-containing reads mapped to corresponding sites at 
each time point.  
 
Table S6. Coordinates of 3ʹ UTR for all CDSs existing and novel. This table 
includes the coordinates of all 3ʹ UTRs detected for both annotated and novel 
CDSs and the number of poly(T)-containing reads mapped to corresponding 
sites at each time point.  
 
Table S7. Characterization of novel ORFs. This table contains detailed 
information of novel identified ORFs, including strand, boundary coordinates of 
ORFs and transcripts, whether or not the signal peptide, transmembrane domain, 
or GPI-anchor signal was present, CDD output.  
 
Table S8. Putative alternative start codon in T. cruzi. This table includes the 
coordinates of all putative alternative start codon. 
 
Table S9. Acceptor sequence usage for primary and alternative trans-
splicing sites. This table includes the frequency of acceptor sequence applied 





Table S10. T. cruzi trans-splicing site detected in non-CDS region. This table 
includes the coordinates of trans-splicing sites detected inside annotated CDSs 
and the number of SL-containing reads mapped to corresponding sites at each 
time point. 
 
Table S11. Genes with different primary trans-splicing site usage across 
stages. This table includes genes that applied different primary trans-splicing site 
at different developmental stages.  
 
Table S12. Summary of alternative splicing events of T. cruzi at stages of 
trypomastigote, epimastigote and amastigote 72 hpi. This table is a 
quantitative presentation of Figure 4, containing the characterization of 
alternative trans-splicing events for each gene, including the number of raw and 
normalized SL-containing reads that mapped to the primary and secondary sites, 
the ratio of P/S at the stages of trypomastigote, epimastigote and amastigote 72 
hpi, the status of alternative splicing, whether there are more than 3 SL-
containing reads mapped to the primary sites, whether P/S >1.6, whether primary 
site switching was present, and whether the secondary site was at least 20 nt 
away from the primary site if existing.  
 
Table S13. T. cruzi 5ʹ UTR coordinates ORF-containing 5ʹ UTRs and 
alternative 5UTRs located less than 20nt excluded. This table includes the 




mapped to corresponding sites at each time point. UTRs containing open reading 
frames or alternative trans-splicing sites less than 20 nt from the primary one 
were excluded from output.  
 
Table S14. Global gene expression profiles of T. cruzi and HFF. This table 
displays quantitative data that were used to plot Figure 34.  
 
Table S15.  Summary of number of DEGs. Table showing number of 
differentially expressed genes each comparison for human and pathogen (q-
value < 0.05).  
 
Table S16. Summary of differential expression analysis for human genes. 
Each sheet reports differential expression results for a specific comparison. The 
columns include gene id, gene function, log2 fold change, P value, q-value, 
adjusted P value, average expression value, and whether the q-value or adjusted 
P value < 0.05 (with Qvals or AdjPvals = 1) . 
 
Table S17. Summary of differential expression analysis for human genes 
with indicator of both q-value and fold change. Each sheet reports differential 
expression results for a specific comparison. The columns include gene id, gene 
function, log2 fold change, P value, q-value, adjusted P value, average 
expression value, and whether the q-value or adjusted P value < 0.05 ( with 





Table S18.  Summary of differential expression analysis for T. cruzi genes. 
Each sheet reports differential expression results for a specific comparison. The 
columns include gene id, gene function, log2 fold change, P value, q-value, 
adjusted P value, average expression value, and whether the q-value or adjusted 
P value < 0.05 ( with Qvals or AdjPvals = 1 ) . 
 
Table S19.  Summary of differential expression analysis for T. cruzi genes 
with indicator of both q-value and fold change. Each sheet reports differential 
expression results for a specific comparison. The columns include gene id, gene 
function, log2 fold change, P value, q-value, adjusted P value, average 
expression value, and whether the q-value or adjusted P value < 0.05 ( with 
Qvals or AdjPvals = 1 ). 
 
Table S20.  Overrepresented T. cruzi genes in a single life stage. In this 
table, genes that were detected as highly expressed in a single life stage are 
represented. Each sheet reports signature genes for amastigote, trypomastigote 
and epimastigote (with or without the limitation of fold change). 
 
Table S21. Enriched Gene Ontology terms for T. cruzi DEGs. This dataset 
contains enriched gene functions for each gene cluster, including the information 
of GO category, over and underrepresented P value, number of gene in the 




adjusted P. value, description of the GO category. Each sheet reports 
overrepresented GO terms under biological process (BP), molecular functions 
(MF), and cellular components (CC) for upregulated or downregulated genes.  
 
Table S22. Enriched Gene Ontology terms for each human DEGs. This 
dataset contains enriched gene functions for each gene cluster, including the 
information of GO category, over and underrepresented P value, number of gene 
in the cluster that were present in the category, number of genes in the category, 
adjusted P. value, description of the GO category.  
 
Table S23. Enriched Gene Ontology terms for each T. cruzi K-mean cluster. 
This dataset contains enriched gene functions for each gene cluster, including 
the information of GO category, over and underrepresented P value, number of 
gene in the cluster that were present in the category, number of genes in the 
category, adjusted P. value, description of the GO category.  
 
Table S24.  Enriched Gene Ontology terms for each human K-mean cluster. 
This dataset contains enriched gene functions for each gene cluster, including 
the information of GO category, over and underrepresented P value, number of 
gene in the cluster that were present in the category, number of genes in the 





Table S25. Motifs identified in the 5’ UTR of K-mean cluster that 
overlapping with the 53 motifs identified in KEGG gene clusters. We 
compared motifs detected in the 5’ UTRs of gene clusters detected in our K-
mean cluster analysis to those that have been identified in KEGG gene cluster. 
The overlapping motifs were indicated by brackets. 
 
Table S26. Motifs identified in the 3’ UTR of K-mean cluster that 
overlapping with the 53 motifs identified in KEGG gene clusters. We 
compared motifs detected in the 3’ UTRs of gene clusters detected in our K-
mean cluster analysis to those that have been identified in KEGG gene cluster. 
The overlapping motifs were indicated by brackets.  
 
Table S27. Intersection between human DEGs and positive results from 
siRNA screening. This table contains genes that were detected differentially 
expressed and were positive in primary siRNA screening. Each sheet reports the 
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